EXPERTS The consolidated financial statements of Cerebras Systems Inc. as of December 31, 2025, and for the year then ended, have been included herein and in the registration statement in reliance upon the report of KPMG LLP, independent registered public accounting firm, appearing elsewhere herein, and upon the authority of said firm as experts in accounting and auditing.
212
Table o f Contents
The consolidated financial statements of Cerebras Systems Inc. as of December 31, 2024, and for the year then ended included in this prospectus and in the registration statement, have been so included in reliance on the report of BDO USA, P.C., an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.
WHERE YOU CAN FIND ADDITIONAL INFORMATION We have filed with the SEC a registration statement on Form S-1, including exhibits and schedules, under the Securities Act, with respect to the shares of Class A common stock being offered by this prospectus. This prospectus, which constitutes part of the registration statement, does not contain all of the information in the registration statement and its exhibits. For further information with respect to us and our Class A common stock, we refer you to the registration statement and its exhibits. Statements contained in this prospectus as to the contents of any contract or any other document referred to are not necessarily complete, and in each instance, we refer you to the copy of the contract or other document filed as an exhibit to the registration statement. Each of these statements is qualified in all respects by this reference. You may read our SEC filings, including this registration statement, over the Internet at the SEC’s website at www.sec.gov. Upon the completion of this offering, we will be subject to the information reporting requirements of the Exchange Act and we will file reports, proxy statements, and other information with the SEC. These reports, proxy statements, and other information will be available for review at the SEC’s website referred to above. We also maintain a website at www.cerebras.ai, at which, following the completion of this offering, you may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. Information contained on, or that can be accessed through, our website does not constitute part of this prospectus or the registration statement of which it forms a part, and the inclusion of our website address in this prospectus is an inactive textual reference only.
F-1
Table o f Contents
INDEX TO THE CONSOLIDATED FINANCIAL STATEMENTS
Consolidated Financial Statements for the Years Ended December 31, 2025 and 2024
Reports of Independent Registered Public Accounting Firms .......................................................................... ... F-2
Consolidated Balance Sheets ............................................................................................................................ ... F-4
Consolidated Statements of Operations ............................................................................................................ ... F-5
Consolidated Statements of Comprehensive Income (Loss) ............................................................................ ... F-6
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Deficit .................. ... F-7
Consolidated Statements of Cash Flows ........................................................................................................... ... F-8
Notes to the Consolidated Financial Statements ............................................................................................... ... F-9
F-2
Table o f Contents
Report of Independent Registered Public Accounting Firm Shareholders and Board of Directors Cerebras Systems Inc. Sunnyvale, California Opinion on the Consolidated Financial Statements We have audited the accompanying consolidated balance sheet of Cerebras Systems Inc. (the “Company”) as of December 31, 2024, the related consolidated statements of operations, comprehensive income (loss), redeemable convertible preferred stock and stockholders’ deficit, and cash flows for the year ended December 31, 2024, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2024, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America. Basis for Opinion These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provides a reasonable basis for our opinion. /s/ BDO USA, P.C. We served as the Company’s auditor from 2020 to 2025. San Jose, California September 18, 2025
F-3
Table o f Contents
Report of Independent Registered Public Accounting Firm To the Stockholders and Board of Directors Cerebras Systems Inc.: Opinion on the Consolidated Financial Statements We have audited the accompanying consolidated balance sheet of Cerebras Systems Inc. and subsidiaries (the Company) as of December 31, 2025, the related consolidated statements of operations, comprehensive income (loss), redeemable convertible preferred stock and stockholders’ deficit, and cash flows for the year then ended, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025, and the results of its operations and its cash flows for the year then ended, in conformity with U.S. generally accepted accounting principles. Basis for Opinion These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provides a reasonable basis for our opinion. /s/ KPMG LLP We have served as the Company’s auditor since 2025. Santa Clara, California March 31, 2026
F-4
Table o f Contents
CEREBRAS SYSTEMS INC. CONSOLIDATED BALANCE SHEETS (in thousands, except per share and share amounts)
December 31, / December 31, / December 31,
2025 / 2024
ASSETS
Current assets:
Cash and cash equivalents ........................................................................................................... ... $701,706 / $220,208
Restricted cash ............................................................................................................................. ... 228,672 / 361,757
Investments .................................................................................................................................. ... 406,531 / 116,943
Accounts receivable, net .............................................................................................................. ... 50,423 / 137,436
Inventories ................................................................................................................................... ... 63,626 / 174,492
Prepaid expenses and other current assets ................................................................................... ... 92,688 / 19,643
Total current assets ............................................................................................................................ ... 1,543,646 / 1,030,479
Property and equipment, net ............................................................................................................. ... 437,396 / 43,174
Operating lease right-of-use assets .................................................................................................... ... 248,950 / 36,571
Other non-current assets .................................................................................................................... ... 96,045 / 2,514
Total assets ........................................................................................................................................ ... $2,326,037 / $1,112,738
LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable ......................................................................................................................... ... $48,630 / $25,630
Deferred revenue, current ............................................................................................................ ... 131,049 / 38,537
Customer deposits ....................................................................................................................... ... 354,460 / 640,317
Forward contract liability ............................................................................................................ ... — / 363,336
Accrued and other current liabilities ........................................................................................... ... 185,401 / 110,315
Total current liabilities ...................................................................................................................... ... 719,540 / 1,178,135
Operating lease liability, net of current portion ................................................................................ ... 215,957 / 27,370
Other non-current liabilities .............................................................................................................. ... 35,847 / 23,958
Total liabilities .................................................................................................................................. ... $971,344 / $1,229,463
Commitments and contingencies (Note 17)
Redeemable convertible preferred stock, $0.00001 par value per share: 113,258,719 shares and 105,750,455 shares authorized, at December 31, 2025 and 2024, respectively; 113,258,716 and 82,899,159 shares issued and outstanding as of December 31, 2025 and 2024, respectively ................................................................................................................................... ... $1,933,348 / $850,066
Stockholders’ deficit
Class A common stock, $0.00001 par value; 271,800,000 and 204,519,000 shares authorized at December 31, 2025 and 2024, respectively; 57,907,093 and 53,372,691 shares issued and outstanding as of December 31, 2025 and 2024, respectively ...................................................... ... 1 / 1
Class N common stock, $0.00001 par value; 37,100,000 and nil shares authorized at December 31, 2025 and 2024, respectively; nil shares issued and outstanding as of December 31, 2025 and 2024, respectively .................................................................................. ... — / —
Treasury stock, at cost, 889,890 and 300,138 shares as of December 31, 2025 and 2024, respectively ................................................................................................................................... ... (21,456) / (88)
Additional paid-in capital .................................................................................................................. ... 346,829 / 176,233
Accumulated other comprehensive income ...................................................................................... ... 1,301 / 220
Accumulated deficit .......................................................................................................................... ... (905,330) / (1,143,157)
Total stockholders’ deficit ................................................................................................................. ... (578,655) / (966,791)
Total liabilities, redeemable convertible preferred stock, and stockholders’ deficit ........................ ... $2,326,037 / $1,112,738
The accompanying notes are an integral part of these consolidated financial statements.
F-5
Table o f Contents
CEREBRAS SYSTEMS INC. CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data)
Years Ended December 31, / Years Ended December 31, / Years Ended December 31,
2025 / 2024
Revenue
Hardware ............................................................................................................... ... $358,440 / $211,965
Cloud and other services ....................................................................................... ... 151,551 / 78,287
Total revenue ............................................................................................................. ... 509,991 / 290,252
Cost of revenue
Hardware ............................................................................................................... ... 204,746 / 137,310
Cloud and other services ....................................................................................... ... 106,174 / 30,204
Total cost of revenue ................................................................................................. ... 310,920 / 167,514
Gross profit ................................................................................................................ ... 199,071 / 122,738
Operating expenses
Research and development ................................................................................... ... 243,319 / 158,234
Sales and marketing .............................................................................................. ... 70,645 / 20,980
General and administrative ................................................................................... ... 30,969 / 44,962
Total operating expenses ........................................................................................... ... 344,933 / 224,176
Loss from operations ................................................................................................. ... (145,862) / (101,438)
Other income (expense), net ...................................................................................... ... 390,746 / (378,237)
Income (loss) before income taxes ............................................................................ ... 244,884 / (479,675)
Income tax expense ............................................................................................... ... 7,057 / 1,927
Net income (loss) ....................................................................................................... ... 237,827 / (481,602)
Less: Net income attributable to participating securities ........................................... ... 149,952 / —
Less: Deemed dividend on issuance of Series F-1 redeemable convertible preferred stock ........................................................................................................ ... — / 3,182
Net income (loss) attributable to common shareholders ........................................... ... $87,875 / $(484,784)
Net income (loss) per share attributable to common shareholders
Basic ...................................................................................................................... ... $1.64 / $(9.90)
Diluted .................................................................................................................. ... $1.38 / $(9.90)
Weighted average shares used in per share computation: .........................................
Basic ...................................................................................................................... ... 53,616 / 48,972
Diluted .................................................................................................................. ... 171,821 / 48,972
The accompanying notes are an integral part of these consolidated financial statements.
F-6
Table o f Contents
CEREBRAS SYSTEMS INC. CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (in thousands)
Years Ended December 31, / Years Ended December 31, / Years Ended December 31,
2025 / 2024
Net income (loss) ....................................................................................................... ... $237,827 / $(481,602)
Change in foreign currency translation adjustments, net of tax ................................ ... (521) / (304)
Available-for-sale investments:
Change in net unrealized gain (loss) on debt securities, net of tax ....................... ... 1,602 / (579)
Comprehensive income (loss) ................................................................................... ... $238,908 / $(482,485)
The accompanying notes are an integral part of these consolidated financial statements.
F-7
Table o f Contents
CEREBRAS SYSTEMS INC. CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT
Redeemable Convertible Preferred Stock
Redeemable Convertible Preferred Stock / Redeemable Convertible Preferred Stock / Common Stock / Common Stock / Common Stock / Additional Paid-in Capital / Treasury Stock / Treasury Stock / Treasury Stock / Accumulated Other Comprehensive Income (Loss) / Accumulated Deficit / Total Stockholders’ Deficit
(in thousands) .......................... Shares / Amount / Shares / Amount / Additional Paid-in Capital / Shares / Amount / Accumulated Other Comprehensive Income (Loss) / Accumulated Deficit / Total Stockholders’ Deficit
Balance as of December 31, 2023 .................................. ... 77,033 / $722,780 / 45,362 / $— / $101,578 / (300) / $(88) / $1,103 / $(661,555) / $(558,962)
Issuance of shares of Series F-1 redeemable convertible preferred stock, net of issuance costs ..... ... 5,798 / 84,898 / — / — / — / — / — / — / — / —
Settlement of Series F-1 redeemable convertible preferred stock forward contract liability .................. ... — / 37,928 / — / — / — / — / — / — / — / —
Deemed dividend on issuance of Series F-1 redeemable convertible preferred stock .................... ... — / 3,182 / — / — / (3,182) / — / — / — / — / (3,182)
Issuance of shares of Series E redeemable convertible preferred stock upon exercise of warrant .................. ... 68 / 1,278 / — / — / — / — / — / — / — / —
Shares issued upon exercise of stock options, net of repurchases of early exercised stock options ............ ... — / — / 8,011 / 1 / 17,667 / — / — / — / — / 17,668
Vesting of early exercised stock options ........................ ... — / — / — / — / 1,733 / — / — / — / — / 1,733
Stock-based compensation expense ............................... ... — / — / — / — / 57,525 / — / — / — / — / 57,525
Conversion of stock-based liability classified awards to stock-based equity classified awards .................... ... — / — / — / — / 912 / — / — / — / — / 912
Foreign currency translation adjustments, net of tax ..... ... — / — / — / — / — / — / — / (304) / — / (304)
Change in net unrealized loss on debt securities, net of tax .............................................................................. ... — / — / — / — / — / — / — / (579) / — / (579)
Net loss ........................................................................... ... — / — / — / — / — / — / — / — / (481,602) / (481,602)
Balance as of December 31, 2024 .................................. ... 82,899 / $850,066 / 53,373 / $1 / $176,233 / (300) / $(88) / $220 / $(1,143,157) / $(966,791)
Issuance of shares of Series G redeemable convertible preferred stock, net of issuance costs ........................ ... 30,360 / 1,083,282 / — / — / — / — / — / — / — / —
Customer warrants issued............................................... ... — / — / — / — / 152,353 / — / — / — / — / 152,353
Cancellation and settlement of stock options in connection with the Tender Offer ............................. ... — / — / — / — / (49,320) / — / — / — / — / (49,320)
Repurchase of common stock ........................................ ... — / — / — / — / — / (590) / (21,368) / — / — / (21,368)
Shares issued upon acceleration of RSUs vesting and exercise of stock options, net of repurchases and withholding taxes ...................................................... ... — / — / 4,623 / — / 17,169 / — / — / — / — / 17,169
Tax withheld related to RSU settlement ........................ ... — / — / (89) / — / (2,950) / — / — / — / — / (2,950)
Vesting of early exercised stock options ........................ ... — / — / — / — / 3,449 / — / — / — / — / 3,449
Stock-based compensation expense ............................... ... — / — / — / — / 48,857 / — / — / — / — / 48,857
Conversion of stock-based liability classified awards to stock-based equity classified awards .................... ... — / — / — / — / 1,038 / — / — / — / — / 1,038
Foreign currency translation adjustments, net of tax ..... ... — / — / — / — / — / — / — / (521) / — / (521)
Change in net unrealized loss on debt securities, net of tax .............................................................................. ... — / — / — / — / — / — / — / 1,602 / — / 1,602
Net income ..................................................................... ... — / — / — / — / — / — / — / — / 237,827 / 237,827
Balance as of December 31, 2025 .................................. ... 113,259 / $1,933,348 / 57,907 / $1 / 346,829 / $(890) / $(21,456) / $1,301 / $(905,330) / $(578,655)
The accompanying notes are an integral part of these consolidated financial statements.
F-8
Table o f Contents
CEREBRAS SYSTEMS INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands)
Years Ended December 31, / Years Ended December 31, / Years Ended December 31,
2025 / 2024
Cash flows from operating activities:
Net income (loss) .................................................................................................................................. ... $237,827 / $(481,602)
Adjustments to reconcile net income (loss) to net cash flows provided by (used in) operating activities:
Depreciation and amortization ................................................................................................. ... 34,454 / 11,537
Stock-based compensation ....................................................................................................... ... 49,767 / 58,564
Non-cash lease expense ............................................................................................................ ... 22,673 / 7,607
Provision for product warranties .............................................................................................. ... 20,969 / 12,525
Change in fair value (extinguishment) of forward contract liability ........................................ ... (363,336) / 401,264
Other ......................................................................................................................................... ... 3,235 / (1,388)
Changes in operating assets and liabilities:
Accounts receivable ............................................................................................................ ... 87,012 / (130,672)
Inventories .......................................................................................................................... ... 63,307 / (144,969)
Prepaid expenses and other assets ...................................................................................... ... (13,867) / (17,051)
Accounts payable ................................................................................................................ ... 21,151 / 9,010
Deferred revenue ................................................................................................................ ... 109,474 / 38,196
Customer deposits .............................................................................................................. ... (285,857) / 640,317
Other liabilities ................................................................................................................... ... 3,141 / 48,640
Net cash flows provided by (used in) operating activities .................................................................... ... (10,050) / 451,978
Cash flows from investing activities:
Purchases of property and equipment ............................................................................................. ... (382,739) / (23,435)
Purchases of investments ................................................................................................................ ... (525,414) / (302,898)
Maturities and sales of investments ................................................................................................ ... 240,577 / 309,548
Net cash flows used in investing activities ........................................................................................... ... (667,576) / (16,785)
Cash flows from financing activities:
Proceeds from sale of shares of redeemable convertible preferred stock ....................................... ... 1,100,000 / 85,000
Costs incurred in connection with the sale of shares of redeemable convertible preferred stock .. ... (16,718) / (102)
Proceeds from exercise of stock options ........................................................................................ ... 17,299 / 27,752
Repurchases of early exercised stock options ................................................................................ ... (28) / (28)
Cancellation and settlement of stock options in connection with the Tender Offer ....................... ... (49,320) / —
Repurchase of common stock ......................................................................................................... ... (21,368) / —
Tax withheld related to RSU settlement ......................................................................................... ... (2,950) / —
Payments of deferred offering costs ............................................................................................... ... (355) / (326)
Net cash flows provided by financing activities ................................................................................... ... 1,026,560 / 112,296
Effect of exchange rate on cash .................................................................................................................. ... (521) / (304)
Increase in cash, cash equivalents, and restricted cash ............................................................................... ... 348,413 / 547,185
Cash, cash equivalents, and restricted cash beginning of period ................................................................ ... 581,965 / 34,780
Cash, cash equivalents, and restricted cash end of period .......................................................................... ... $930,378 / $581,965
Supplemental disclosures of cash flow information:
Income taxes paid ................................................................................................................................. ... $1,699 / $258
Non-cash investing and financing activities:
Transfer to property and equipment out of inventories ........................................................................ ... $67,303 / $18,452
Transfer of property and equipment into inventories ........................................................................... ... $26,534 / $2,456
Purchases of property and equipment included in accounts payable and accrued and other current liabilities ........................................................................................................................................... ... 9,453 / $4,286
Vesting of early exercised options ....................................................................................................... ... $3,449 / $1,733
Right-of-use assets obtained in exchange for lease obligations ........................................................... ... $235,053 / $43,659
Unpaid deferred financing costs included in accrued and other current liabilities .............................. ... $536 / $337
Settlement of Series F-1 redeemable convertible preferred stock forward contract liability ............... ... $— / $37,928
Deemed dividend upon issuance of Series F-1 redeemable convertible preferred stock ..................... ... $— / $3,182
The accompanying notes are an integral part of these consolidated financial statements.
F-9
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Note 1 – Nature of Operations Cerebras Systems Inc. (the “Company” or “Cerebras”) was incorporated in Delaware in April 2016. Cerebras is an artificial intelligence (“AI”) infrastructure company that designs and manufactures an AI compute platform comprised of proprietary systems and software that is delivered in standard racks for deployment in our, and our customers, data centers up to supercomputer scale. The Company’s pioneering Wafer-Scale Engine (“WSE”), a chip encompassing an entire silicon wafer, was specifically designed to enable higher performance and speeds than GPUs for the computational demands of inference, Generative AI (“GenAI”), and other AI applications. Since its inception, Cerebras has dedicated resources to research and development activities that support its current projects and future development efforts. The Company is headquartered in Sunnyvale, California.
Note 2 – Basis of Presentation These consolidated financial statements are presented in U.S. dollars and have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). The consolidated financial statements include the accounts and operations of the Company and its wholly owned subsidiaries. Assets and liabilities of non-U.S. subsidiaries that operate in a local currency environment, where that local currency is the functional currency, are translated to U.S. dollars at exchange rates in effect at the balance sheet date, with the resulting translation adjustments directly recorded in accumulated other comprehensive income (loss). Income and expense accounts are translated at average exchange rates during the year. Remeasurement adjustments are recorded in other income (loss), net. All intercompany accounts and transactions have been eliminated upon consolidation. Certain amounts reported in the prior year financial statements have been reclassified to conform to the current year presentation. These changes in presentation do not affect previously reported results. Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Areas of significant estimates include, but are not limited to, revenue recognition, including the determination of the standalone selling price (“SSP”) of performance obligations, useful life of property, plant and equipment, product warranty accruals, impairment of long-lived assets, the market value of and demand for inventory, valuation allowance on deferred income tax assets, the fair value of common stock and other assumptions used to measure stock-based compensation and the valuation of forward contract liability and warrants. The Company bases its estimates on historical experience, known trends, and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. Actual results could significantly differ from those estimates. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts, and experience. Changes in estimates are recorded prospectively in the period in which they become known.
Note 3 – Recent Accounting Pronouncements Recently Adopted Accounting Pronouncements In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). The guidance requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The Company adopted ASU 2023‑09 on a prospective basis during the year ended December 31, 2025. The adoption did not have a material impact on the Company’s consolidated financial statements or related disclosures. Refer to Note 15 – Income Taxes for further discussion. In May 2025, the FASB issued ASU No. 2025-04, Compensation—Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606): Clarifications to Share-Based Consideration Payable to a
F-10
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Customer (“ASU 2025-04”). ASU 2025-04 reduces diversity in practice and improves the decision usefulness and operability of the guidance for share-based consideration payable to a customer in conjunction with selling goods or services. The ASU is effective for annual reporting periods beginning after December 15, 2026 with updates to be applied on a retrospective or modified retrospective basis. Early adoption is permitted. The Company early adopted ASU 2025-04 for the annual period beginning in fiscal year 2025 on a prospective basis, applying the standard to awards granted after the adoption date. The adoption of ASU 2025-04 did not have a material impact on the Company’s consolidated financial statements. Recent Accounting Pronouncements Not Yet Adopted In November 2024, the FASB issued ASU No. 2024-03, Income Statement—Reporting Comprehensive Income —Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (“ASU 2024-03”). The guidance requires disaggregated information about certain income statement expense line items on an annual and interim basis. This guidance will be effective for annual periods beginning with the year ending December 31, 2027 and for interim periods thereafter. The new standard permits early adoption and can be applied prospectively or retrospectively. The Company is evaluating the effect that this guidance will have on its consolidated financial statements and related disclosures. In September 2025, the FASB issued ASU No. 2025-06, Intangibles: Goodwill and Other‒Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software (“ASU 2025-06”). The guidance modernizes the accounting for software costs and enhances the transparency about an entity’s software costs. The guidance will be effective for the annual periods beginning with the year ending December 31, 2027 and for interim periods beginning January 1, 2028. Early adoption is permitted. Upon adoption, the guidance can be applied prospectively, retrospectively, or under a modified transition approach. The Company is evaluating the effect that this guidance will have on its consolidated financial statements and related disclosures and does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.
Note 4 – Significant Accounting Policies Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers, which provides a five-step framework through which revenue is recognized when control of promised goods or services is transferred to a customer at an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To determine revenue recognition for arrangements that the Company concludes are within the scope of ASC 606, management performs the following five steps: (i) identifies the contract(s) with a customer; (ii) identifies the performance obligations in the contract(s); (iii) determines the transaction price, including whether there are any constraints on variable consideration; (iv) allocates the transaction price to the performance obligations; and (v) recognizes revenue when (or as) the Company satisfies a performance obligation. Revenue is recognized when control of the promised goods or services, through performance obligations by the Company, is transferred to the customer in an amount that reflects the consideration it expects to be entitled to in exchange for the performance obligations. The Company combines and accounts for multiple contracts as a single contract when they are negotiated together with the same customer at or near the same time in order to achieve a single commercial objective. Transaction price may be comprised of fixed consideration, variable consideration, significant financing component, non-cash consideration, and consideration payable to a customer. The Company’s contracts are typically for fixed consideration. Contracts may also include variable consideration such as incentives, credits, price protection and other incentive programs. Variable consideration is estimated at contract inception and updated each reporting period and is included in the transaction price only to the extent it is probable that a significant reversal of cumulative revenue will not occur.
F-11
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
The Company uses judgment to determine whether a contract includes a significant financing component. Such contracts generally arise when a customer makes an upfront payment and the period between receipt of payment and the transfer of the promised services exceeds one year. Contracts determined to include a significant financing component are discounted using the Company’s incremental borrowing rate. In these cases, the Company records a contract liability and recognizes interest expense over the period between receipt of the advance payment and transfer of the promised services. As the Company satisfies its performance obligations and recognizes revenue under these contracts, the related contract liability is reduced. Amounts payable to a customer is accounted for as a reduction of the transaction price unless the payment is in exchange for a distinct good or service received from the customer. Non-cash consideration, including equity- classified instruments issued to a customer, is measured at fair value at issuance and is included in the transaction price. For equity classified instruments that are fully vested upon issuance, the associated fair value is included as customer warrants and recognized as a reduction of revenue as the related goods or services are transferred to the customer. For instruments subject to vesting conditions, the grant-date fair value of each tranche is included in the transaction price when management determines that the tranche is probable of vesting, and is recognized as a reduction of revenue as the related goods or services are transferred to the customer in proportion to the revenue recognized. For all contracts with customers that have more than one performance obligation, the Company allocates the transaction price to each separate performance obligation based on the relative SSP of each performance obligation. Certain contracts include options that allow customers to acquire additional goods or services at prices below the expected standalone selling price. These options provide a material right to the customer and are accounted for as separate performance obligations. The best evidence of an SSP, if available, is the observable price charged in similar circumstances and to similar customers. If an SSP is not directly observable, the Company estimates SSP using various observable inputs including historical internal pricing data, cost-plus expected margin analysis, market conditions and information about the size and/or purchase volume of the customer, due to the limited standalone sales history. The Company generates revenue primarily from the sale of on-premise and cloud solutions in the form of AI Systems, cloud capacity offerings, and support services, including custom AI modeling services. Hardware Sales Revenue and Installation, Integration, and Acceptance Testing Hardware revenue primarily consists of sales of the Company’s AI systems and other equipment. Revenue from the sale of AI systems is recognized upon transfer of control of promised goods to customers at a point in time. Revenue is recorded net of customer incentives and any taxes collected from customers. Generally, control of the goods transfers to the customer upon shipment, or delivery, depending on shipping terms, in the absence of installation, integration, and acceptance testing requirements. In certain cases, the Company may be contracted to install the hardware at the customer’s facility, and subsequent to installation, the Company may provide further integration services and conduct acceptance testing. When installation, integration, and acceptance testing is bundled with the hardware, control of the goods is transferred upon meeting the contractual acceptance provisions. Transaction price allocated to installation and integration services is recognized at a point in time upon completion of services, which generally coincides with the timing of customer acceptance and recognition of revenue for the AI system. Revenue for installation and integration services is included in Cloud and other services revenue on the consolidated statements of operations. Customers may also purchase other equipment as needed, such as racks, coolant distribution units, and power supply units. In arrangements where another party is involved in providing specified goods or services to a customer, the Company evaluates whether it is the principal or agent. In this evaluation, the Company considers if control of the specified goods or services is obtained before they are transferred to the customer, as well as other indicators such as the party primarily responsible for fulfillment, inventory risk, and discretion in establishing price. Revenue recognized from sales of additional equipment follows similar revenue recognition patterns as hardware sales.
F-12
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Support Services The Company sells support services, including software updates and customer care support, with terms ranging from one-year to five-year terms. The support services represent an obligation of the Company to stand-ready to provide an undefined quantity of support when and as needed by the customer over the duration of the service term. These arrangements represent stand-ready obligations to provide services over the contract term, and revenue is recognized ratably as the customer simultaneously receives and consumes the benefits of the services. Operations and Management Services The Company provides a comprehensive suite of services to manage and operate clusters of systems located at data centers leased by the Company, where customer-owned equipment is installed, as well as clusters of systems at customer premises. These services include managing and maintaining large-scale infrastructure, regular software updates, hardware maintenance, and 24x7 monitoring of system and facility health. Revenue is recognized on a straight-line basis over the service term as the customer simultaneously receives and consumes the benefits of the services provided. Cloud-based Computing Services The Company also provides cloud-based computing services to customers. In applying ASC 606, the Company evaluates whether the arrangement meets the definition of a lease under ASC 842 which requires the transfer of control of the identified asset. The Company determined that while it provides cloud computing services utilizing underlying hardware, generally customers do not control or direct the use of underlying hardware. In each case, the totality of services provided represents a single integrated solution tailored to the customer’s specific needs. As such, the performance obligations to the customers consist of a single integrated solution delivered as a series of distinct daily services. The customers benefit from the services over the contract term and as such revenue is recognized over time as services are provided. AI Modeling Services The Company also generates revenue from custom AI modeling service agreements with customers, whereby the Company is engaged to help customers throughout the AI workflow, starting with developing strategy, designing and building the model, and deploying the final model. The totality of services in such arrangements is broken into different milestones within the contract. In certain contracts, each milestone builds upon progress achieved in earlier milestones. Upon completion of each milestone, the Company provides a deliverable to the customer in certain contracts, which must be accepted by the customer in order to proceed with the next phase of the contract. Each milestone is typically for fixed consideration. The Company recognizes revenue from AI modeling services over time as services are provided or at a point in time upon completion and acceptance by the customer of contract deliverables, depending on the terms of the agreement. Product Warranties The Company offers product warranties ranging from one to five years against any defective products. These standard warranties are assurance-type warranties, and the Company does not offer any services beyond the assurance that the product will continue working as specified. Therefore, these warranties are not considered separate performance obligations in the arrangement. Based on historical experience, the Company accrues for estimated returns of defective products at the time revenue is recognized. The Company monitors warranty obligations and may make revisions to its warranty reserve if actual costs of product repair and replacement are significantly higher or lower than estimated. Warranty accruals are based on estimates that are updated on an ongoing basis taking into consideration inputs such as new product introductions, changes in the volume of claims compared with the Company’s historical experience, and the changes in the cost of servicing warranty claims. The Company accounts for the effect of such changes in estimates prospectively. Estimated warranty costs are accrued at the time of sale and recognized in cost of revenue, with a corresponding warranty liability included in accrued and other current liabilities.
F-13
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Research and Development Costs Research and development costs are expensed in the period incurred. Research and development expenses primarily consist of costs incurred in performing research and development activities and include salaries, stock- based compensation, employee benefits, tape-out costs (which include layout services, mask sets, prototype components), system qualification and testing incurred before releasing new system designs into production, data center costs, depreciation and amortization, professional services fees, cloud computing costs and facilities expenses. The Company expenses software development costs before technological feasibility is reached. The majority of these costs are expenses incurred to develop the software component of the hardware we sell, lease, or market to external users. Technological feasibility is typically reached shortly before the release of such products. As a result, development costs that meet the criteria for capitalization were not material for the periods presented. Stock-Based Compensation The Company’s 2016 Equity Incentive Plan (as amended, the “Equity Incentive Plan”) provides for the Company to grant incentive stock options (“ISOs”), non-statutory stock options (“NSOs”), restricted stock units (“RSUs”), and restricted stock awards (“RSAs”) to employees, advisers, and directors. The Company measures stock-based compensation awards exchanged for employee services at fair value on the date of the grant and recognizes expense on a straight-line basis over the award’s vesting period. The requisite service period generally equals the vesting period of the awards. The Company estimates the grant date fair value of ISOs and NSOs using the Black-Scholes option-pricing model. The fair value of RSUs and RSAs are based on the Company’s stock price on the date of grant. The Company estimates forfeitures at the date of grant, based on historical experience, and revises, if necessary, in subsequent periods if actual forfeitures differ from those estimates. For certain equity awards that have both service and performance conditions, the Company recognizes the expense using the accelerated attribution method over the requisite service period if it is probable that the performance conditions will be achieved. The Company reassesses the achievement of the performance conditions at each reporting date and adjusts the stock- based compensation accordingly. Income Taxes The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets (“DTAs”) and deferred tax liabilities (“DTLs”) for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, DTAs and DTLs are determined on the basis of the differences between the financial statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on DTAs and DTLs is recognized in income in the period that includes the enactment date. The Company recognizes DTAs to the extent that these assets are more likely than not to be realized. In making such a determination, all available positive and negative evidence is considered, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If it is determined that the DTAs in the future in excess of their net recorded amount can be realized, an adjustment to the DTA valuation allowance will be made, which would reduce the provision for income taxes. Due to the Company’s historical operating performance and net losses, the Company’s U.S. federal and state net deferred tax assets have been fully offset by a valuation allowance. Management makes estimates, assumptions and judgments to determine the Company’s provision for or benefit from income taxes, deferred tax assets and liabilities, uncertain tax positions and any valuation allowances recorded against the Company’s deferred tax assets. Changes in recognition or measurement of uncertain tax positions are reflected in the period in which the judgment occurs. The Company's policy is to recognize interest and penalties related to the underpayment of income taxes as a component of the provision for income taxes.
F-14
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Cash and Cash Equivalents Cash and cash equivalents include cash on hand and highly liquid investments with an original maturity of three months or less at the time of purchase. The Company’s cash and cash equivalents are invested in various investment grade institutional money market funds and interest-bearing accounts. Restricted Cash Restricted cash includes cash and cash equivalents that are not readily available for use in the Company’s operating activities. Restricted cash is primarily attributable to cash advances received from customers that the Company is contractually restricted to use for the limited purposes of satisfying obligations under contracts with its customers. See “Customer Deposits” for additional information. Investments Investments consist primarily of time deposits and U.S. Treasury securities that have an initial maturity of greater than three months at the time of purchase but less than or equal to one year at period-end. The Company classifies its investments in debt securities as available for sale. These available-for-sale debt securities are reported at fair value. The fair value of interest-bearing debt securities includes accrued interest. Debt securities are carried at fair value, with the unrealized gains and losses reported as a component of accumulated other comprehensive income (loss) (“AOCI”), except for the changes in allowance for expected credit losses, which are recorded in other income (expense), net. The Company determines any realized gains or losses on the sale of, or maturity of, debt securities on a specific identification method, and the Company records such realized gains and losses in other income (expense), net. All of the Company’s available-for-sale debt securities are evaluated at each reporting date for credit losses. If the Company intends to sell a security, or if it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis, the security is written down to its fair value and the entire unrealized loss is recognized in earnings. For all other available-for-sale debt securities in an unrealized loss position, the Company evaluates whether a credit loss exists based on available information relevant to the collectability of the security, including past events, current conditions, and reasonable and supportable forecasts. The portion of the unrealized loss attributable to credit factors is recognized in earnings, limited to the total unrealized loss, with the remaining unrealized loss recognized in accumulated other comprehensive income (loss). There were no credit losses or impairment charges for the years ended December 31, 2025 and 2024. Fair Value of Financial Instruments The Company determines fair value measurements used in its consolidated financial statements based upon the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy distinguishes between (i) market participant assumptions developed based on market data obtained from independent sources (observable inputs), and (ii) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below: •Level 1 inputs are quoted prices in active markets for identical assets and liabilities; •Level 2 inputs, other than quoted prices included within Level 1, are observable for the asset or liability either directly or indirectly; and
F-15
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
•Level 3 inputs are not observable in the market. The fair value hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The carrying amounts of the Company’s financial instruments consisting of cash and cash equivalents, accounts receivable, accounts payable, and accrued liabilities approximate fair value due to their relatively short maturities. Refer to Note 8 – Investments, Note 9 – Fair Value Measurements, Note 12 – Redeemable Convertible Preferred Stock, and Note 13 – Common Stock for further discussion. Accounts Receivable Payment terms for accounts receivables vary by contract: some customers prepay, while others, subject to credit evaluation, are billed in arrears, typically within one year. Accounts receivable are stated at a gross invoice amount less an allowance for credit losses as well as net of any discounts or other forms of estimated variable consideration. We estimate allowance for credit losses by evaluating specific accounts where information indicates our customers may have an inability to meet financial obligations, such as customer payment history, creditworthiness and receivable amounts outstanding for an extended period beyond contractual terms. We use assumptions and judgment, based on the best available facts and circumstances, to record an allowance to reduce the receivable to the amount expected to be collected. These allowances are evaluated and adjusted as additional information is received. We had no allowance for credit losses as of December 31, 2025 and 2024. During the years ended December 31, 2025 and 2024, we recognized $0.2 million and nil of expense related to credit losses, respectively. Inventories Inventories consist of raw materials, work-in-progress, and finished goods and are stated at the lower of cost or net realizable value. Costs are measured on a weighted average cost basis. Inventory costs consist primarily of the cost of semiconductors, memory products, and other component parts purchased from subcontractors, including wafer fabrication, assembly, testing, and manufacturing support costs, including labor and overhead associated with such purchases, final test yield fallout, and shipping costs. The Company’s process and product development lifecycle includes substantive engineering milestones that are consistently applied to determine when activities and related costs transition from research and development to cost of revenue and when such costs are capitalized as inventory. Inventory is valued at the lower of cost or net realizable value, based upon assumptions about future demand and market conditions. Net realizable value is the estimated selling price of the Company’s products in the ordinary course of business less reasonably predictable costs of completion, disposal, and transportation. Inventories are written down to their net realizable value if they have become obsolete, have a cost basis in excess of expected net realizable value, or are in excess of expected demand. Once inventory is written down, the reduced carrying value becomes the new cost basis and is maintained until it is sold, scrapped, or written down for further valuation losses. The valuation of inventories requires the Company to make judgments based on currently available information about the likely method of disposition and current and future product demand relative to the remaining product life. The Company also evaluates inventory for excess quantities, obsolescence, and items that are not of salable quality. Cost of revenue is charged for inventory provisions to write down inventory to the lower of cost or net realizable value or to completely write off excess or obsolete inventory. Most inventory provisions relate to write- downs for inventory that is not of salable quality. Contract Assets Contract assets include deferred cost of sales related to revenue that has not yet been recognized and unbilled receivables that relate to our contractual right to consideration for completed performance obligations. Unbilled receivables are reclassified to receivables when the right to consideration becomes unconditional, and contract assets attributable to future revenues are recognized as a reduction of revenue as the related goods or services are
F-16
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
transferred to the customer. Contract assets are evaluated for expected credit losses, excluding amounts recorded for fully vested equity instruments issued to a customer. Refer to Note 10 – Balance Sheet Details for further discussion. Property and Equipment, Net Property and equipment are recorded at cost, less accumulated depreciation. Expenditures for major additions and improvements to property and equipment are capitalized and repairs and maintenance costs are expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the respective accounts and any related gain or loss is recognized. Property and equipment are depreciated using the straight-line method over the estimated useful lives of the property and equipment as follows:
Asset Category / Useful Life (Years)
Data center and computer equipment ............................... ... 3–5
Machinery and equipment ................................................ ... 7
Leasehold improvements .................................................. ... Lesser of estimated useful life or remaining lease term
Estimated useful lives are periodically assessed to determine if changes are appropriate. Such revisions may result, for example, from changes to plans, demand, or strategy for the Company’s inference solutions. Leases The Company primarily enters into arrangements as a lessee and does not have material arrangements in which it acts as a lessor. The Company determines if an arrangement is a lease at its inception. Operating leases with lease terms of more than 12 months are included in right-of-use assets and operating lease liabilities in the consolidated balance sheets. Right-of-use assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. Operating lease liabilities and right-of-use assets are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments if an implicit rate is not available. The right-of-use assets also includes any rent prepayments, lease incentives upon receipt, and straight-line rent expense impacts, which represent the differences between operating lease liabilities and right-of-use assets. Lease terms include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease and non-lease components have been combined. Impairment of Long-Lived Assets The Company assesses the recoverability of its long-lived assets, including property and equipment and right- of-use assets, for indicators of impairment. If events or changes in circumstances indicate that an asset may be impaired, the Company evaluates recoverability by comparing the asset’s carrying amount to the estimated undiscounted future cash flows expected to be generated by the asset or asset group. If the carrying amount exceeds the estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount exceeds the assets fair value. When quoted market prices are not available, fair value is estimated using expected future cash flow discounted at a rate commensurate with the risks associated with the assets’ recovery. No impairment of long-lived assets was identified for the years ended December 31, 2025 and 2024.
F-17
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Contract Liabilities The timing of customer billings and payments relative to the start of the service period varies from contract to contract, resulting in contract liabilities consisting of either deferred revenue or customer deposits. Deferred revenue represents billings under noncancelable contracts before the related product or service is transferred to the customer. Customer Deposits The Company receives advance payments from customers for anticipated purchases of high-performance computing systems and related services. These amounts are recorded as customer deposits until purchase orders are received and the related products or services are delivered. In certain arrangements, the deposits are used to make payments to third-party vendors to manufacture infrastructure. If purchase orders are not received, any portion of the deposit not paid to third-party vendors is refundable to the customer on demand, and the Company’s rights to inventory purchased with the deposit transfer to the customer in accordance with the contractual terms. Forward Contract Liability The Company determined that its obligation to issue, and the Company’s investors’ obligation to purchase, shares of Series F-1 and Series F-2 redeemable convertible preferred stock at a fixed price in the future represented a freestanding financial instrument (“forward contract liability”) and is classified as a liability because the underlying shares of the forward contract liability are redeemable upon the occurrence of certain events outside the control of the Company. This liability is measured at fair value upon initial recognition and at each subsequent reporting date through the settlement date, with changes in fair value for each reporting period recognized in other income (expense), net on the consolidated statements of operations. Refer to Note 12 – Redeemable Convertible Preferred Stock for further discussion. The Company has concluded that the forward purchase obligation related to the Series F-1 Preferred Stock, previously recognized as a liability, should be derecognized as of April 15, 2025, as the underlying redeemable shares were not exercised. The contractual expiration of the investors’ commitment constituted a legal release from the obligation, thereby extinguishing the liability. Deferred Offering Costs Deferred offering costs, consisting of legal, accounting, and other fees and costs relating to the Company’s proposed initial public offering, are capitalized within other assets on the condensed consolidated balance sheet. The deferred offering costs will be offset against the proceeds received by the Company upon the completion of the planned initial public offering. In the event the planned initial public offering is terminated, all of the deferred offering costs will be expensed as general and administrative expense. As of December 31, 2025 and 2024, the deferred offering costs were $0.9 million and nil, respectively. Treasury Stock The Company records repurchases of common shares as treasury stock at cost and records subsequent retirements of treasury shares at cost. The amount of cash or other assets transferred to repurchase an equity award is charged to equity to the extent that the amount paid does not exceed the fair value of the equity instrument being repurchased at the repurchase date. Any amount paid in excess of fair value is attributed to the other elements of the transaction and accounted for according to their substance. If treasury shares are retired, the excess of the repurchase price over the par value of the shares acquired is allocated to both accumulated deficit and additional paid-in capital. The portion allocated to additional paid-in capital is calculated on a pro rata basis of the shares to be retired and the total shares issued and outstanding as of the date of retirement.
F-18
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Concentration of Risk The Company is subject to certain risks and uncertainties that could have a material adverse effect on its business, financial condition, results of operations, or cash flows primarily due to concentration of credit risk, significant customers, and supplier concentration. Concentration of Credit Risk Financial instruments that potentially expose the Company to significant concentration of credit risk consist primarily of cash, cash equivalents, restricted cash, investments and accounts receivable. The Company maintains its cash, cash equivalents, restricted cash, and marketable securities with high-quality financial institutions mainly in the United States, where the composition and maturities of which are regularly monitored by the Company. The Company holds cash, cash equivalents, and restricted cash at several major financial institutions, which may exceed insurance limits set by the Federal Deposit Insurance Corporation (“FDIC”). The Company grants credit to its customers in the normal course of business, exposing it to credit risk in the event of nonrepayment by customers. The Company has not experienced any material losses to date from these financial instruments. Significant Customers A limited number of customers may account for a significant portion of the Company’s revenue or accounts receivable in certain periods. Refer to Note 5 – Revenue for further discussion. Supplier Concentration Certain materials used by the Company in the manufacturing of its products are available from a limited number of suppliers. Shortages could occur in these materials due to an interruption of supply or increased demand in the industry. Two suppliers accounted for 19% and 14% of total purchases for the year ended December 31, 2025. Three suppliers accounted for 21%, 14%, and 11% of total purchases for the year ended December 31, 2024.
Note 5 – Revenue Disaggregation of Revenue The Company recognizes revenue classified in hardware at a point in time, and revenue classified in cloud and other services either at a point in time or over time. Revenue by point in time and over time was as follows (in thousands):
Years Ended December 31, / Years Ended December 31, / Years Ended December 31,
2025 / 2024
Hardware revenue recognized point in time .............................................................. ... $358,440 / $211,965
Cloud and other services revenue recognized point in time ...................................... ... 2,194 / 628
Cloud and other services revenue recognized over time ........................................... ... 149,357 / 77,659
Total revenue ....................................................................................................... ... $509,991 / $290,252
Revenue recognized during the year ended December 31, 2025 that was included in deferred revenue as of December 31, 2024 was $34.5 million. Revenue recognized during the year ended December 31, 2024 that was included in deferred revenue as of December 31, 2023 was $13.7 million.
F-19
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Significant Customers Customers that each accounted for 10% or more of our total revenues were as follows:
Percentage of Total Revenues For the Year Ended December 31, / Percentage of Total Revenues For the Year Ended December 31, / Percentage of Total Revenues For the Year Ended December 31,
2025 / 2024
Customer A ............................................................................................................. ... 62% / *
Customer B ............................................................................................................. ... 24% / 85%
_____________ (1)Customer A and Customer B are considered related parties with respect to each other as defined by ASC 850, Related Party Disclosures. *Percentage was less than 10% Customers that each accounted for 10% or more of accounts receivable balances as of the periods presented are as follows:
As of December 31, / As of December 31, / As of December 31,
2025 / 2024
Customer A ............................................................................................................. ... 78% / *
Customer B ............................................................................................................. ... * / 91%
______________ (1)Customer A and Customer B are considered related parties with respect to each other as defined by ASC 850, Related Party Disclosures. *Percentage was less than 10% OpenAI Collaboration In December 2025, the Company entered into a Master Relationship Agreement (the “MRA”) with OpenAI OpCo, LLC (“OpenAI”) to provide 750MW of AI inference compute capacity that OpenAI is contractually committed to purchase (the “Committed Capacity”) and related services over a multi-year term. The MRA includes (i) a services arrangement pursuant to which the Company will provide the Committed Capacity and related services over a term of three or four years that is extendable by OpenAI to a maximum of five years in total, (ii) a secured promissory note of approximately $1.0 billion (the “Working Capital Loan”) funded by OpenAI in January 2026 to support the build-out of infrastructure and related capabilities required to deliver such services, and (iii) a warrant to purchase shares of the Company’s Class N common stock. Refer to Note 13 – Common Stock for further discussion. No revenue was recognized for this arrangement during the year ended December 31, 2025. In addition to the Committed Capacity, OpenAI has the option to purchase an additional 1.25GW of AI inference compute capacity (the “Additional Capacity”) for deployment in tranches by the end of 2030 for up to a total of 2.0GW. Remaining Performance Obligation Revenue allocated to remaining performance obligations that is unsatisfied (or partially unsatisfied), which includes deferred revenue and amounts that are expected to be invoiced and recognized as revenue in future periods, was $24.6 billion as of December 31, 2025. A significant amount of the balance was attributable to the Company’s obligations pursuant to a master relationship agreement with OpenAI. The Company expects to recognize approximately 15% of this revenue over the initial 24 months ending December 31, 2027, 43% between months 25 and 48, and the remaining balance recognized thereafter. However, time periods for revenue recognition may vary from the foregoing due to changes in timing of delivery at the customer’s request or otherwise. The remaining performance obligations exclude revenue related to performance obligations for contracts with a length of one year or less.
F-20
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
The arrangement with OpenAI includes variable consideration related to pass-through costs that are included in the transaction price. These pass-through costs primarily consist of data center leasehold improvements, fixed monthly rental costs, security and other variable monthly lease costs such as power and other utilities. Amounts related to these pass-through costs are included in the transaction price and the remaining performance obligations for the initial 250MW of Committed Capacity. Pass-through costs associated with Committed Capacity in excess of the initial 250MW are excluded from remaining performance obligations because the related consideration is highly susceptible to factors outside the Company’s control which involves significant amounts that will be determined over the remaining years of the MRA. Revenue related to pass-through costs will be recognized as the underlying Committed Capacity is delivered and is reported on a gross basis.
Note 6 – Segment and Geographical Information The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is regularly evaluated by the chief operating decision maker (“CODM”), which is the Company’s Chief Executive Officer, in deciding how to allocate resources and assess performance. Net income (loss) is the Company’s primary measure of profit or loss, and all costs and expenses categories on the Company’s consolidated statements of operations, as well as stock-based compensation, depreciation and amortization expenses, are significant. The Company’s CODM reviews net income or loss on a quarterly basis to assess overall operating performance, evaluate profitability and determine resource allocation, including capital spending and operating expense priorities. Refer to Note 14 – Stock-Based Compensation and Note 10 – Balance Sheet Details for further discussion. The Company’s segment items also primarily include changes in the fair value of forward contract liabilities, and interest and dividend income. The measure of segment assets is reported on the consolidated balance sheet as total assets. Revenue by geographic area is designated based upon the billing location of the customer. Revenue by geographic areas were as follows (in thousands)
Years Ended December 31, / Years Ended December 31, / Years Ended December 31,
2025 / 2024
United States .............................................................................................................. ... $187,643 / $282,685
Europe, Middle East, and Africa ............................................................................... ... 322,231 / 7,567
Other .......................................................................................................................... ... 117 / —
Total revenue ........................................................................................................ ... $509,991 / $290,252
Property and equipment by geographic area was as follows (in thousands):
As of December 31, / As of December 31, / As of December 31,
2025 / 2024
United States .............................................................................................................. ... $376,021 / $43,142
Other .......................................................................................................................... ... 61,375 / 32
Total property and equipment ............................................................................... ... $437,396 / $43,174
Note 7 – Net Income (Loss) Per Share The Company follows the two-class method when computing net income (loss) per ordinary share when shares are issued that meet the definition of participating securities. The two-class method determines net income (loss) per ordinary share for each class of ordinary shares and participating securities according to dividends declared or accumulated and participation rights in undistributed earnings. The two-class method requires income available to ordinary shareholders for the period to be allocated between ordinary shares and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. Our participating securities include all series of our redeemable convertible preferred stock. Undistributed earnings allocated to these participating securities are subtracted from net income in determining net income attributable to common
F-21
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
stockholders. Basic net income (loss) per share is computed by dividing net income attributable to common stockholders by the weighted-average number of shares of our common stock outstanding, adjusted for outstanding shares that are subject to repurchase. Shares issuable upon exercise of certain warrants for Class N common stock are considered in-substance outstanding for basic net income (loss) per share because the exercise price is nominal and the issuance of shares is considered probable; accordingly, such shares are included in the weighted-average shares outstanding for purposes of basic net income (loss) per share, although no Class N shares have been legally issued as of December 31, 2025. Diluted net income (loss) per share attributable to common stockholders is computed by dividing net income attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period, adjusted to give effect to potentially dilutive securities. The Company’s potentially dilutive securities include shares of redeemable convertible preferred stock and stock-based awards. Shares of redeemable convertible preferred stock are assumed to be converted into common stock using the if-converted method from the beginning of the period, or from the date of issuance if later. Under the if-converted method, any dividends on such preferred stock, whether declared or accumulated, are added back to net income attributable to common stockholders in the calculation of diluted net income per share. Stock options are included in the calculation of diluted net income per share using the treasury stock method. For periods in which the Company reports a net loss, all potentially dilutive securities are excluded from the computation of diluted net loss per share as their inclusion would be anti-dilutive. Dilutive securities in our diluted net income (loss) per share calculation do not include unvested RSUs. Vesting of these RSUs is dependent upon the satisfaction of both a service condition and a liquidity condition. The liquidity condition is satisfied upon the occurrence of a qualifying event, such as the completion of an initial public offering. As of December 31, 2025, such a qualifying event had not occurred and until it occurs, the holders of these RSUs have no rights in our undistributed earnings. Therefore, they are excluded from the effect of dilutive securities. For the year ended December 31, 2025, no potential common shares were excluded from diluted net income per share as their effect would have been anti-dilutive. For the year ended December 31, 2024, the following potential common shares were excluded from the computation of diluted net loss per share because their inclusion would have been anti-dilutive:
Year ended December 31,
2024
Redeemable convertible preferred stock ............................................................................................... ... 82,899,159
Early exercised shares subject to repurchase ........................................................................................ ... 1,373,428
Options to purchase common stock ...................................................................................................... ... 35,033,929
Total potential common stock excluded from net loss per share .................................................... ... 119,306,516
F-22
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
The following is a reconciliation of the numerator and denominator of the basic and diluted net income per share computations for the periods presented:
Years Ended December 31, / Years Ended December 31, / Years Ended December 31,
2025 / 2024
(in thousands, except per share data) / (in thousands, except per share data) / (in thousands, except per share data)
Numerator:
Net income (loss) .................................................................................................. ... $237,827 / $(481,602)
Less: Net income attributable to participating securities ...................................... ... 149,952 / —
Deemed dividend upon issuance of Series F-1 redeemable convertible preferred stock .............................................................................................. ... — / 3,182
Net income (loss) attributable to common stockholders ...................................... ... $87,875 / $(484,784)
Denominator:
Basic weighted-average common shares net of shares subject to repurchase ...... ... $53,616 / $48,972
Dilutive impact of outstanding redeemable convertible preferred stock (as-if converted basis) ................................................................................................. ... 91,491 / —
Dilutive impact of outstanding stock options ....................................................... ... 26,714 / —
Dilutive weighted-average common shares .......................................................... ... $171,821 / $48,972
Net income (loss) per share:
Basic ...................................................................................................................... ... $1.64 / $(9.90)
Diluted .................................................................................................................. ... $1.38 / $(9.90)
Note 8 – Investments The Company classifies its U.S. Treasury securities, which are accounted for as available-for-sale, and time deposits within Level 2 in the fair value hierarchy because it uses quoted market prices to the extent available or alternative pricing sources and models utilizing market observable inputs to determine fair value. There were no transfers between Level 1 and Level 2 as of December 31, 2025 and 2024. The following tables summarize the Company’s investments (in thousands):
As of December 31, 2025
As of December 31, 2025 / As of December 31, 2025 / As of December 31, 2025 / As of December 31, 2025 / As of December 31, 2025 / As of December 31, 2025 / As of December 31, 2025 / As of December 31, 2025 / As of December 31, 2025 / As of December 31, 2025
Fair Value Hierarchy / Amortized Cost / Gross Unrealized Gains / Gross Unrealized Losses / Accrued Interest / Fair Value
U.S. Treasury securities .................... ... Level 2 / $404,321 / $2,174 / $— / $— / $406,495
Time deposits ................................... ... Level 2 / 36 / — / — / — / 36
Total ............................................. ... $404,357 / $2,174 / $— / $— / $406,531
As of December 31, 2024
As of December 31, 2024 / As of December 31, 2024 / As of December 31, 2024 / As of December 31, 2024 / As of December 31, 2024 / As of December 31, 2024 / As of December 31, 2024 / As of December 31, 2024 / As of December 31, 2024 / As of December 31, 2024
Fair Value Hierarchy / Amortized Cost / Gross Unrealized Gains / Gross Unrealized Losses / Accrued Interest / Fair Value
U.S. Treasury securities .................... ... Level 2 / $115,124 / $1,204 / $— / $6 / $116,334
Time deposits ................................... ... Level 2 / 609 / — / — / — / 609
Total ............................................. ... $115,733 / $1,204 / $— / $6 / $116,943
The Company recognized gross realized gains of $0.2 million and nil for the years ended December 31, 2025 and 2024, respectively. The Company recognized gross realized losses of nil for the years ended December 31, 2025 and 2024. The Company reflects these gains and losses as a component of other income (expense), net.
F-23
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
All of the Company’s investments have a stated contractual maturity date of less than one year.
Note 9 – Fair Value Measurements Assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):
Fair Value Measurements
Fair Value Measurements / Fair Value Measurements / Fair Value Measurements / Fair Value Measurements
Balance Sheet Captions .................. As of December 31, 2025 / Level 1 / Level 2 / Level 3 / Total Gains
Cash and cash equivalents
Money market funds ............................... ... $598,544 / $598,544 / $— / $— / $—
U.S. Treasury securities .......................... ... 101,845 / — / 101,845 / — / 632
Restricted cash
Money market funds ............................... ... 224,006 / 224,006 / — / — / —
Investments
U.S. Treasury securities .......................... ... 406,495 / — / 406,495 / — / 2,374
Time deposits .......................................... ... 36 / — / 36 / — / —
Total Investments ............................... ... 406,531 / — / 406,531 / — / 2,374
_______________ (1)Unrealized gains from remeasurement of U.S. Treasury securities has been recognized in AOCI. Realized gains have been recognized in Other income (expense).
Fair Value Measurements
Fair Value Measurements / Fair Value Measurements / Fair Value Measurements / Fair Value Measurements
Balance Sheet Captions .................. As of December 31, 2024 / Level 1 / Level 2 / Level 3 / Total Gains (Losses)
Cash and cash equivalents
Money market funds ............................... ... $216,748 / $216,748 / $— / $— / $—
Restricted cash
Money market funds ............................... ... 361,757 / 361,757 / — / — / —
Investments
U.S. Treasury securities .......................... ... 116,334 / — / 116,334 / — / 1,204
Time deposits .......................................... ... 609 / — / 609 / — / —
Total Investments ............................... ... 116,943 / — / 116,943 / — / 1,204
Forward contract liability .............. 363,336 / — / — / 363,336 / (401,264)
Other non-current liabilities
Warrants .................................................. ... $— / $— / $— / $— / $(165)
_____________ (1)Unrealized gains from the remeasurement of U.S. Treasury securities have been recognized in AOCI. Losses from remeasurement of the forward contract liability and warrants have been recognized as other income (expense), net.
F-24
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Note 10 – Balance Sheet Details Inventories were composed of the following (in thousands):
As of December 31, / As of December 31, / As of December 31,
2025 / 2024
Raw materials ............................................................................................................ ... $15,939 / $77,168
Work in progress ....................................................................................................... ... 10,968 / 37,838
Finished goods ........................................................................................................... ... 36,719 / 59,486
Total inventories ................................................................................................... ... $63,626 / $174,492
As of December 31, 2025 and 2024, the Company’s provision for excess and obsolete inventory was $0.9 million. During the years ended December 31, 2025 and 2024, the Company recorded a charge of approximately $6.8 million and $3.6 million, respectively, to cost of revenue related to provision for excess, obsolete, and scrapped inventory, primarily related to the transition to the next generation of the Company’s product offering. Prepaid expenses and other current assets consisted of the following (in thousands):
As of December 31, / As of December 31, / As of December 31,
2025 / 2024
Customer warrants ..................................................................................................... ... 60,906 / —
Unbilled receivables .................................................................................................. ... 16,244 / 9,252
Prepaid expenses ........................................................................................................ ... 8,196 / 6,461
Taxes receivable ........................................................................................................ ... 4,795 / 464
Other receivables and current assets .......................................................................... ... 2,547 / 3,466
Total prepaid expenses and other current assets ................................................... ... $92,688 / $19,643
Property and equipment, net consisted of the following (in thousands):
As of December 31, / As of December 31, / As of December 31,
2025 / 2024
Data center and computer equipment ........................................................................ ... $277,421 / $49,847
Machinery and equipment ......................................................................................... ... 25,370 / 4,817
Leasehold improvements ........................................................................................... ... 22,348 / 3,950
Construction in progress ............................................................................................ ... 163,451 / 7,775
Property and equipment ........................................................................................ ... 488,590 / 66,389
Less: accumulated depreciation ................................................................................. ... (51,194) / (23,215)
Total property and equipment, net ........................................................................ ... $437,396 / $43,174
F-25
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Depreciation expense included in the consolidated statements of operations was as follows (in thousands):
Years Ended December 31, / Years Ended December 31, / Years Ended December 31,
2025 / 2024
Cost of revenue .......................................................................................................... ... $12,699 / $3,150
Research and development ........................................................................................ ... 14,513 / 6,536
Sales and marketing ................................................................................................... ... 7,186 / 1,095
General and administrative ........................................................................................ ... 56 / 756
Total depreciation expense ................................................................................... ... $34,454 / $11,537
Other non-current assets consisted of the following (in thousands):
As of December 31, / As of December 31, / As of December 31,
2025 / 2024
Customer warrants, non-current ................................................................................ ... $91,447 / $—
Other non-current assets ............................................................................................ ... 4,598 / 2,514
Total non-current assets ........................................................................................ ... $96,045 / $2,514
Accrued and other current liabilities were composed of the following (in thousands):
As of December 31, / As of December 31, / As of December 31,
2025 / 2024
Accrued purchases and expenses ............................................................................... ... $59,458 / $58,428
Operating lease liability, current................................................................................ ... 45,865 / 13,303
Sales tax payable ....................................................................................................... ... 35,577 / 1,950
Accrued compensation .............................................................................................. ... 16,611 / 9,271
Product warranty liability .......................................................................................... ... 9,368 / 17,043
Liability related to early exercised options ................................................................ ... 5,187 / 8,534
Other .......................................................................................................................... ... 13,335 / 1,786
Total accrued and other current liabilities ............................................................ ... $185,401 / $110,315
The following table shows the changes in provision for product warranty during the year ended December 31, 2025 and 2024 (in thousands):
Years Ended December 31, / Years Ended December 31, / Years Ended December 31,
2025 / 2024
Balance at beginning of year ..................................................................................... ... $17,043 / $3,633
Additions during the year .......................................................................................... ... 20,969 / 41,190
Utilization during the year ......................................................................................... ... (28,644) / (27,780)
Balance at end of year ........................................................................................... ... $9,368 / $17,043
F-26
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Other non-current liabilities were composed of the following (in thousands):
As of December 31, / As of December 31, / As of December 31,
2025 / 2024
Deferred revenue, net of current portion ................................................................... ... $35,847 / $18,885
Other liabilities .......................................................................................................... ... — / 5,073
Total other non-current liabilities ......................................................................... ... $35,847 / $23,958
Note 11 – Other Income (Expense), Net Other income (expense), net were comprised of the following (in thousands):
Years Ended December 31, / Years Ended December 31, / Years Ended December 31,
2025 / 2024
Change in (fair value) and extinguishment of forward contract liability .................. ... $363,336 / $(401,264)
Interest and dividend income ..................................................................................... ... 26,802 / 23,228
Other .......................................................................................................................... ... 608 / (201)
Total other income (expense), net ......................................................................... ... $390,746 / $(378,237)
Note 12 – Redeemable Convertible Preferred Stock The Company had the following shares of redeemable convertible preferred stock, $0.00001 par value per share, authorized, issued, and outstanding as of December 31, 2025 and 2024 (in thousands, except for share amounts):
As of December 31, 2025
Shares Authorized / Shares Issued and Outstanding / Liquidation Preference / Net Carrying Value
Series A redeemable convertible preferred stock ................ ... 31,731,394 / 31,731,394 / $26,972 / $26,924
Series B redeemable convertible preferred stock ................ ... 9,076,079 / 9,076,079 / 25,000 / 24,955
Series C redeemable convertible preferred stock ................ ... 7,264,680 / 7,264,680 / 65,000 / 64,952
Series D redeemable convertible preferred stock ................ ... 4,943,849 / 4,943,849 / 79,822 / 79,735
Series E redeemable convertible preferred stock ................ ... 14,916,649 / 14,916,649 / 272,096 / 273,301
Series F redeemable convertible preferred stock ................. ... 9,168,419 / 9,168,419 / 254,376 / 254,191
Series F-1 redeemable convertible preferred stock ............. ... 5,798,089 / 5,798,089 / 85,000 / 126,008
Series G redeemable convertible preferred stock ................ ... 30,359,560 / 30,359,557 / 1,100,000 / 1,083,282
Total ..................................................................................... ... 113,258,719 / 113,258,716 / $1,908,266 / $1,933,348
As of December 31, 2024
Shares Authorized / Shares Issued and Outstanding / Liquidation Preference / Net Carrying Value
Series A redeemable convertible preferred stock ....... ... 31,731,394 / 31,731,394 / $26,972 / $26,924
Series B redeemable convertible preferred stock ....... ... 9,076,079 / 9,076,079 / 25,000 / 24,955
Series C redeemable convertible preferred stock ....... ... 7,264,680 / 7,264,680 / 65,000 / 64,952
Series D redeemable convertible preferred stock ....... ... 4,943,849 / 4,943,849 / 79,822 / 79,735
Series E redeemable convertible preferred stock ....... ... 14,916,649 / 14,916,649 / 272,096 / 273,301
Series F redeemable convertible preferred stock ....... ... 9,168,419 / 9,168,419 / 254,376 / 254,191
Series F-1 redeemable convertible preferred stock .... ... 28,649,385 / 5,798,089 / 85,000 / 126,008
Total ........................................................................... ... 105,750,455 / 82,899,159 / $808,266 / $850,066
F-27
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Conversion The preferred stock is convertible, at any time at the option of its holder, into fully paid and nonassessable Class A common shares at a 1:1 ratio, subject to appropriate adjustment for splits, dividends, other similar recapitalization activity. Conversion of all classes of preferred stock to Class A common shares is mandatory in the event of a qualified initial public offering with proceeds of at least $500.0 million. Voting The holders of the preferred stock are entitled to vote, together with the holders of common shares, as a single class, on all matters submitted to the stockholders for a vote. Each share of preferred stock is entitled to a number of votes equal to the number of common shares into which such preferred stock is convertible as of the record date for determining stockholders entitled to vote. Dividends The holders of shares of redeemable convertible preferred stock are entitled to receive non-cumulative dividends, out of any assets legally available for such purpose, prior and in preference to any declaration or payment of any dividend on the shares of common stock, when, as and if, declared by our board of directors. After payment of such dividend to the preferred stockholders, outstanding shares of preferred stock shall participate with shares of common stock on an as-converted basis as to any additional dividends. As of December 31, 2025 the Company had not declared any dividends. Liquidation preference In the event of any voluntary or involuntary liquidation, dissolution, or winding-up of the Company or deemed liquidation events, the holders of preferred stock then outstanding are entitled to be paid out of the funds and assets available for distribution to its stockholders an amount per share equal to the greater of (a) the original issue price for such series of preferred stock, plus any dividends declared but unpaid, or (b) such amount per share as would have been payable had all shares of such series of preferred stock been converted into common stock immediately prior to such liquidation, dissolution, winding-up, or deemed liquidation event. Redemption In addition, holders of the preferred stock are eligible to demand redemption of their shares in the event of certain deemed liquidation events, as defined in the agreement. Due to the various rights and privileges within the existing preferred stock and common stockholder agreements, the Company concluded the triggering of a deemed liquidation event is not solely within the control of the Company and, accordingly, has presented the preferred stock as temporary equity. As of December 31, 2025, the Company determined that a deemed liquidation event is not probable because there are currently no plans for a change of control, merger or consolidation, or sale of substantially all assets. Therefore, subsequent remeasurement of preferred stock presented in temporary equity is not required. As of each reporting date and on an ongoing basis, the Company will continue to assess the probability of redemption. Series E Warrants In 2020, the Company entered into an equity arrangement with one of its customers whereby the Company issued a warrant that is exercisable for up to 68,213 shares of its Series E redeemable convertible preferred stock. The warrant is classified as a liability and remeasured to fair value and falls under Level 3 of the fair value hierarchy. The Company provided services and issued the warrant to the customer, and the customer paid the consideration to the Company for the provision of services. The warrant had a contractual term of seven years and an exercise price of $0.00001 per share. The customer was able to either exercise the warrant at the exercise price or
F-28
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
convert a portion of the warrant into a number of shares of the Company’s Series E redeemable convertible preferred stock adjusted to equal the fair market value, less the exercise price. The warrant was exercised and settled in August 2024. The fair value of warrants is determined using a Black-Scholes option-pricing model as of the grant date. The amount representing the fair value of the equity provided to the customer from the warrant is recognized as adjustments to revenue in the consolidated statements of operations and comprehensive loss over the term of such commercial agreement or based on the achievement of certain performance targets in accordance with ASC 505-50. As of the settlement date, the fair value of the warrant accrued was determined using the following assumptions:
August 7, 2024
Remaining contractual life (years) ........................................................................................................ ... 3.00
Expected volatility (%) ......................................................................................................................... ... 59.48
Expected risk-free interest rate (%) ...................................................................................................... ... 3.81
Dividend yield (%) ................................................................................................................................ ... —
The following table provides a reconciliation of the beginning and ending balances for the Level 3 warrant liability measured at fair value using significant unobservable inputs (in thousands):
Warrant Liability
Balance as of January 1, 2024 ............................................................................................................... ... $1,113
Change in fair value ......................................................................................................................... ... 165
Exercise and settlement of warrant liability ..................................................................................... ... (1,278)
Balance as of December 31, 2024 ......................................................................................................... ... $—
For the year ended December 31, 2024, the change in fair value related to the warrant was recognized in other income (expense), net. No fair value remeasurement was recorded for the year ended December 31, 2025. Series F-1 and F-2 In May 2024, the Company entered into a Series F-1 redeemable convertible preferred stock purchase agreement (the “Series F-1 Preferred Stock Agreement”) with various investors to issue up to 27,285,129 shares of the Company’s Series F-1 redeemable convertible preferred stock (“Series F-1 Preferred Stock”), of which 22,851,296 shares were allocated to be purchased by an entity affiliated with Group 42 Holding Ltd (together with its affiliates, “G42”) for an aggregate purchase price of $335 million, subject to regulatory approval (the “G42 Primary Purchase”). The agreement also provided G42 with an option to purchase certain additional shares in the Company at a 17.5% discount to the then-current fair market value, contingent upon G42 purchasing between $500.0 million and $5.0 billion of additional products and services (the “G42 Option”). In July 2024, the Company and G42 filed a Joint Voluntary Notice with the Committee on Foreign Investment in the United States (“CFIUS”) seeking regulatory approval of the G42 Primary Purchase, which remained pending through the end of 2024. The Series F-1 Preferred Stock Agreement was subsequently amended in July 2024 to increase the total number of Series F-1 Preferred Stock offered for sale to 28,649,385 shares, and amended and restated in September 2024 to change the securities to be purchased by G42 from Series F-1 Preferred Stock to Series F-2 redeemable convertible preferred stock (“Series F-2 Preferred Stock”), which had the same rights, preferences, and privileges as the Series F-1 Preferred Stock except voting rights (as amended and restated, the “Series F-1 and F-2 Preferred Stock Purchase Agreement”). Between July and September 2024, all shares of the Series F-1 Preferred Stock not allocated to the G42 Primary Purchase were purchased by various investors for gross proceeds of $85.0 million. The Series F-1 and F-2 Preferred Stock Purchase Agreement provided that either the Company or G42 could terminate the agreement if the closing of the G42 Primary Purchase does not occur by April 15, 2025.
F-29
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Following engagement with CFIUS, the Company and G42 agreed in principle in the first quarter of 2025 to amend the Series F-1 and F-2 Preferred Stock Purchase Agreement to remove G42 as a party, and to enter into a new stock purchase agreement for the purchase of non-voting preferred stock if G42 consummates the G42 Primary Purchase. The Company and G42 also agreed in principle to revise the G42 May 2024 Agreement to remove product pricing and volume commitments. Based on the foregoing representations, CFIUS granted the Company’s request to withdraw the Joint Voluntary Notice on March 27, 2025. Because the G42 Primary Purchase was not consummated by April 15, 2025, no new stock purchase agreement was ultimately entered into, and consistent with the agreement in principle, the Series F-1 and F-2 Agreement was restated in the third quarter of 2025 to remove G42 as a party, including the termination of the G42 Option. The G42 May 2024 Agreement was also terminated in its entirety. Forward Contract Liability The commitments made by the investors to purchase shares of the Company’s certain series of redeemable convertible preferred stock at a future date for a discounted fixed price of $14.66 per share represented forward contracts between the Company and the counterparties. The forward contracts were classified as a liability and remeasured to fair value at each reporting date, with changes in fair value recorded to other income (expense), net. In September 2024, an investor settled its forward contract by purchasing the underlying preferred shares, and that forward contract was remeasured at a fair value of $27.02 per share as of the settlement date. The forward contracts were considered to be a Level 3 liability in the fair value hierarchy due to certain unobservable inputs. The primary input in the valuation of the forward contract liability was the fair value of the Company’s underlying redeemable convertible preferred stock, which were determined in accordance with the applicable elements of the American Institute of Certified Public Accountants guide, Valuation of Privately Held Company Equity Securities Issued as Compensation, and derived from a hybrid method that considered both an option pricing model (“OPM”) and the probability weighted expected return method (“PWERM”) to allocate the value among the Company’s classes of securities. The OPM was based on the Black-Scholes-Merton option pricing model, which allows for the identification for a range of possible future outcomes, each with an associated probability. The OPM is appropriate to use when the range of possible future outcomes is difficult to predict and thus creates highly speculative forecasts. PWERM involves a forward-looking analysis of the possible future outcomes of the enterprise including an initial public offering as well as non-initial public offering market-based outcomes. As of December 31, 2024, the fair value of the Company’s underlying redeemable convertible preferred stock was $30.56 per share. As the G42 Primary Purchase was not consummated by April 15, 2025, the forward contract was extinguished. The following table provides a reconciliation of the beginning and ending balances for forward contract liability measured at fair value using significant unobservable inputs (in thousands):
Balance as of January 1, 2024 ............................................................................................................... / $—
Fair value at inception of contract .................................................................................................... ... —
Change in fair value ......................................................................................................................... ... 401,264
Settlement of Series F-1 redeemable convertible preferred stock forward contract liability ........... ... (37,928)
Balance as of December 31, 2024 ......................................................................................................... ... 363,336
Extinguishment of forward contract liability ................................................................................... ... (363,336)
Balance as of December 31, 2025 ......................................................................................................... ... $—
For the years ended December 31, 2025 and 2024, the change in fair value and extinguishment of the forward contract liability were recognized in other income (expense), net. Series G In September 2025, the Company entered into a Series G redeemable convertible preferred stock purchase agreement with various investors to issue up to 30,359,560 shares of the Company’s Series G redeemable
F-30
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
convertible preferred stock. The Company raised $1.1 billion, net of issuance costs, through issuance of 30,359,557 shares of Series G redeemable convertible preferred stock through October 2025. Series H In January 2026, the Company entered into a Series H redeemable convertible preferred stock purchase agreement with various investors. Refer to Note 18 – Subsequent Events for further discussion.
Note 13 – Common Stock The Company has two classes of authorized common stock: Class A common stock and Class N common stock. The rights of holders of Class A common stock and Class N common stock are identical, except with respect to voting and conversion rights. Each holder of Class A common stock is entitled to one vote per share, and each holder of Class N common stock is entitled to no votes per share. Each share of Class N common stock shall automatically convert to one fully paid and nonassessable share of Class A common stock upon the occurrence of a common transfer, meaning any direct or indirect sale, exchange, redemption, assignment, distribution, gift, retirement, transfer, conveyance, or other disposition. Permitted transferees include entities under common control with or controlled by such holder of the Class N common stock or if the holder provides prior written notice to the Company electing for the transfer to not result in a conversion. Once converted into Class A common stock, the Class N common stock will not be reissued. As of December 31, 2025 and 2024, respectively, the Company was authorized to issue 271,800,000 shares and 204,519,000 shares of Class A common stock, $0.00001 par value per share. As of December 31, 2025 and 2024, respectively, the Company had 57,907,093 and 53,372,691 shares of Class A common stock issued and outstanding, of which 772,584 and 1,373,428 shares of Class A common stock were subject to repurchase as of such date for early exercised stock options. As of December 31, 2025 and 2024, respectively, the Company was authorized to issue 37,100,000 shares and nil shares of Class N common stock, $0.00001 par value per share. As of December 31, 2025 and 2024, respectively, the Company had nil shares of Class N common stock issued and outstanding. As of December 31, 2025 and 2024, the Company had 889,890 and 300,138 shares of common stock held as treasury shares, respectively which may be used for issuance under the Equity Incentive Plan. All shares that were issued upon early exercise of stock options are considered legally issued and outstanding. However, for accounting purposes, only shares that are fully vested or are not subject to repurchase are considered issued and outstanding. Below is a reconciliation of shares issued and outstanding:
As of December 31, / As of December 31, / As of December 31,
2025 / 2024
Total shares of common stock legally issued and outstanding (including shares issued upon early exercise of stock options) .......................................................... ... 57,907,093 / 53,372,691
Less: Shares subject to repurchase for early exercised stock options ....................... ... (772,584) / (1,373,428)
Total shares issued and outstanding not subject to repurchase ............................. ... 57,134,509 / 51,999,263
The voting, dividend, and liquidation rights of the holders of the Company’s shares of common stock are subject to and qualified by the rights, powers, and preferences of the holders of shares of the Company’s redeemable convertible preferred stock. Each share of Class A common stock entitles the holder to one vote on all matters submitted to a vote of the Company’s stockholders. Subject to preferences that may be applicable to any then outstanding preferred stock, holders of common stock are entitled to receive dividends as may be declared from time
F-31
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
to time by our board of directors out of legally available funds; provided, however, that if a dividend is paid in the form of common stock (or rights to acquire, or securities convertible into or exchangeable for, such shares), then the holders of the Class A common stock shall receive shares of Class A common stock (or rights to acquire, or securities convertible into or exchangeable for, such shares, as the case may be) and holders of Class N common stock shall receive shares of Class N common stock (or rights to acquire, or securities convertible into or exchangeable for, such shares, as the case may be), unless a disparate dividend treatment of the shares of each such class is approved by the affirmative vote of the holders of a majority of the then-outstanding shares of Class A common stock and Class N common stock, each voting separately as a class, subject to the preferential dividend rights of the preferred shares. Through December 31, 2025, no cash dividends had been declared or paid by the Company. Tender Offer In October 2025, the Company launched a tender offer to certain employees to purchase a maximum cash outlay of $100.0 million of up to an aggregate of 2,759,960 shares of the Company’s Class A common stock, including cancellation and settlement of shares of common stock underlying eligible options and repurchase of settled RSU shares from eligible sellers (the “Tender Offer”), at a purchase price of $36.23 per share. As part of the Tender Offer, the Company modified the liquidity event condition with respect to 185,387 RSUs for which the service-based vesting condition had been satisfied. The Company issued 96,848 shares, net of withholding taxes, upon vesting of the RSUs, and 69,584 shares were repurchased by the Company pursuant to the Tender Offer. Refer to Note 14 – Stock-Based Compensation for further discussion. In connection with the Tender Offer, the Company canceled and settled 1,567,013 shares underlying eligible stock options. Additionally, the Company repurchased 589,752 shares of common stock as part of the Tender Offer. The repurchased shares were recorded as treasury stock at cost and reflected as an addition to stockholders’ deficit. The Tender Offer was completed in December 2025 and resulted in a total cash outflow of $70.7 million. Of this amount, $49.3 million associated with settlement of eligible options was recorded as a reduction of additional paid-in capital and $21.4 million was recorded in treasury stock within stockholders’ deficit. Warrants G42 Warrant In December 2025, the Company issued a warrant to G42 to purchase an aggregate of up to 1,857,516 shares of Class N Common Stock at an exercise price of $0.01 per share (“the G42 Warrant”). The warrant was fully vested and immediately exercisable upon issuance, and expired five days from the date of issuance. The warrant is classified as an equity instrument, and the grant-date fair value was $82.02 per share. The G42 Warrant was exercised in full in January 2026. The Company recorded a customer warrant asset of $152.4 million as of December 31, 2025, all of which will be recognized as a reduction of revenue in the consolidated statement of operations in proportion to the amount of related revenues, which could occur until October 2031. OpenAI Warrant Concurrent with the MRA, as discussed in Note 5 – Revenue, the Company issued to OpenAI a warrant to purchase up to an aggregate of up to 33,445,026 shares of the Company’s Class N common stock at an exercise price of $0.00001 per share (the “OpenAI Warrant”). The OpenAI Warrant vests in multiple tranches upon achievement of specified milestones associated with the MRA, including funding of the Working Capital Loan, delivery of the Committed Capacity and Additional Capacity in tranches, and certain market capitalization or
F-32
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
customer payment thresholds. As of December 31, 2025, the Company concluded that vesting of the tranches related to the Working Capital Loan, the Committed Capacity, and the tranche that vests upon the earlier of achieving specified market capitalization or customer payment thresholds under the MRA were probable of vesting, while the remaining tranches associated with the Additional Capacity were not considered probable of vesting. Subject to certain terms and conditions, the OpenAI Warrant expires on the earlier of December 24, 2035 and five business days following the first date during which there is no binding capacity purchase commitments or contractually obligated current or future payments under the MRA. The OpenAI Warrant is classified as an equity instrument, and the grant-date fair value was $82.02 per share. None of the warrant shares had met the vesting or exercise conditions as of December 31, 2025, and the issuance of the warrant had no impact on the Company’s consolidated financial statements other than disclosure of a subsequent event as well as remaining performance obligations for the year ended December 31, 2025.
Note 14 – Stock-Based Compensation The Equity Incentive Plan provides for the Company to grant ISOs, NSOs, RSUs, and RSAs to employees, advisers, and directors. As of December 31, 2025 and 2024, there were 81,357,316 and 65,711,838 equity awards authorized, respectively. Stock Options Stock options represent the right to purchase shares of common stock on the date of exercise at a stated exercise price. The exercise price of a stock option generally must be at least equal to the fair market value of the common stock on the date of grant. Options generally vest over periods of four years or more and are exercisable over a period of time not to exceed 10 years from the grant date. The terms of the plan permit certain option holders to exercise options before their options are vested, subject to certain limitations. Upon early exercise, the awards become subject to a restricted stock agreement. The shares of restricted stock granted upon early exercise of the options are subject to the same vesting provisions in the original stock option awards. Shares issued as a result of early exercise that have not been vested are subject to repurchase by the Company upon termination of the option holder’s employment, at the price paid by the option holder. Such shares are not deemed to be issued for accounting purposes until they vest. The liability is reclassified into common stock and additional paid-in capital as the shares vest and the repurchase right lapses. As of December 31, 2025 and 2024, 772,584 and 1,373,428 unvested shares, respectively, were held by employees. Accordingly, the Company recorded the unvested portion of the exercise proceeds of $5.2 million and $8.5 million as a liability from the early exercise in the accompanying consolidated balance sheets as of December 31, 2025 and 2024, respectively. The following table summarizes the Company’s stock option activity and related information:
Number of Shares
Weighted Average Exercise Price / Aggregate Intrinsic Value (in thousands) / Weighted Average Remaining Life
Outstanding, as of January 1, 2025 ............................. ... 35,033,929 / $4.85 / $777,294 / $7.25
Exercised during period .......................................... ... (4,442,639) / $3.91
Forfeited .................................................................. ... (648,116) / $6.29
Tender Offer options canceled and settled .......... ... (1,567,013) / $4.79
Expired .................................................................... ... (14,454) / $5.55
Outstanding and Exercisable, as of December 31, 2025 ..................................................................... ... 28,361,707 / $4.97 / $2,185,162 / $6.40
______________ (1)Refer to Note 13 – Common Stock for further discussion.
F-33
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
The aggregate intrinsic value of options is calculated as the difference between the exercise price of the stock options and the fair value of the Company’s shares of common stock for those options that had exercise prices lower than the fair value of the Company’s shares of common stock. The total intrinsic value for stock options exercised during the years ended December 31, 2025 and 2024, was $110.6 million and $72.0 million, respectively. The weighted-average grant date fair value of options granted was $5.21 per share for the year ended December 31, 2024. No options were granted for the year ended December 31, 2025. As of December 31, 2025 and 2024, the total remaining unrecognized compensation expense related to unvested stock options was $33.2 million and $60.8 million, respectively, which will be amortized over the weighted-average period of 1.78 years and 2.33 years, respectively. The fair value of each option award is determined on the date of grant using the Black-Scholes option-pricing model. The calculation of fair value includes several assumptions that require management’s judgment. Due to the absence of a public market for the Company’s common stock, the Company’s board of directors relies on the assistance of management and external valuation experts to estimate the fair value of its common stock for purposes of granting options and for determining stock-based compensation expense. A reasonable valuation method is used and considers several objective and subjective factors, including obtaining contemporaneous independent third-party valuations, actual and forecasted operating and financial results, market conditions and performance of comparable publicly traded companies, developments and milestones in the Company, the rights and preferences of redeemable convertible preferred stock and common stock, and transactions involving the Company’s stock. The fair value of the Company’s common stock was determined in accordance with applicable elements of the American Institute of Certified Public Accountants guide, Valuation of Privately Held Company Equity Securities Issued as Compensation. The estimated fair value of stock options was determined using the Black-Scholes option-pricing model with the following weighted-average assumptions:
December 31, 2024
Expected term of options (years) .......................................................................................................... ... 6.01
Expected volatility (%) ......................................................................................................................... ... 59.2
Risk-free interest rate (%) ..................................................................................................................... ... 3.68 - 4.68
Expected dividend yield (%) ................................................................................................................. ... —
No options were issued for the year ended December 31, 2025. Expected term: The expected term of the stock options represents the period of time stock options are expected to be outstanding and is based on the “simplified method.” Under this method, the term is estimated using the midpoint between the requisite service period and the contractual term of the option. This method is used due to the lack of sufficient historical exercise data. Expected volatility: The expected volatility is a measure of the amount by which a financial variable, such as a share price has fluctuated (historical volatility) or is expected to fluctuate (expected volatility) during a period. As the Company does not yet have a sufficient history of its own volatility, the Company has identified several public entities of similar complexity and industry and calculates historical volatility based on the volatilities of these companies. Risk-free interest rate: The risk-free interest rate is based on U.S. Treasury yield curve in effect at the time of grant. Expected dividend yield: No dividends have been paid or expected to be paid by the Company.
F-34
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
RSUs RSUs represent a right to receive one share of common stock for each RSU that vests. The Company has granted RSUs that vest on satisfaction of both service- and liquidity-based vesting conditions. The service-based vesting condition for these equity awards is generally satisfied by rendering continuous service through the applicable vesting period, which is generally four years. The liquidity-based vesting condition is satisfied upon the occurrence of an initial public offering, direct listing, or sale of our company, given prevailing market conditions. Unless otherwise determined by the Board of Directors at the time of grant, service-based vesting ceases on the date the participant no longer provides services to the Company. If both the service-based vesting condition and the liquidity-based vesting condition of an RSU are not satisfied, such RSU is forfeited. If an RSU has not been forfeited and both the service- and liquidity-based vesting conditions have been satisfied, then on the date specified in the RSUs, the Company delivers to the holder a number of whole shares of common stock subject to any withholdings to cover tax obligations. Dividend equivalents, if any, are not credited in respect of shares covered by the RSUs, except as otherwise permitted by the Compensation Committee. As of December 31, 2025 and 2024, the Company had 15,229,068 and 4,909,256 unvested RSUs, respectively. The following table summarizes RSU activity and related information:
Number of Shares / Weighted Average Grant Date Fair Value
Outstanding as of January 1, 2025 ............................................................................. ... 4,909,256 / $18.08
Granted .................................................................................................................. ... 11,154,655 / $27.65
Tender Offer RSU modified and settled ............................................................ ... (185,387) / $24.35
Forfeited ................................................................................................................ ... (649,456) / $25.15
Outstanding as of December 31, 2025 ....................................................................... ... 15,229,068 / $24.72
____________ (1) Refer to Note 13 – Common Stock for further discussion. As of December 31, 2025 and 2024, the total remaining unrecognized compensation expense related to unvested RSUs was $343.5 million and $79.1 million, respectively. This unrecognized compensation expense will be recognized when the liquidity-based vesting condition becomes probable for certain RSUs that have a performance condition, and service-based vesting condition will be satisfied over the weighted-average period of 2.91 years and 1.75 years, respectively. Total stock-based compensation expense for years ended December 31, 2025 and 2024 was as follows (in thousands):
Years Ended December 31, / Years Ended December 31, / Years Ended December 31,
2025 / 2024
Cost of revenue .......................................................................................................... ... $827 / $921
Research and development ........................................................................................ ... $32,154 / $41,397
Sales and marketing ................................................................................................... ... $9,950 / $8,723
General and administrative ........................................................................................ ... $6,836 / $7,523
Total stock-based compensation expense ............................................................. ... $49,767 / $58,564
Approximately $0.9 million and $1.0 million of the compensation expense recognized for each of the years ended December 31, 2025 and 2024, respectively, was attributed to certain share-based awards, which provided the employee the option to choose between equity or cash, of which approximately $0.5 million and $0.6 million was included in accrued and other current liabilities on the consolidated balance sheets as of December 31, 2025 and 2024, respectively.
F-35
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Approximately $14.1 million and $30.7 million of the compensation expense recognized for the years ended December 31, 2025 and 2024, respectively, was attributed to sales of shares of common stock by certain current and former employees of the Company to certain existing equity holders in the Company, through secondary market transactions, where the excess price paid above fair value for shares was recorded as stock-based compensation expense. Modification of stock-based awards As part of the Tender Offer, the Company modified the liquidity-event condition with respect to 185,387 RSUs for which the service-based vesting condition had been satisfied. Specifically, the liquidity-event condition was waived, such that those RSUs became fully vested on December 2, 2025, and settled in shares of Class A Common Stock that were eligible to be sold in the Tender Offer. The Company accounted for the modification of the RSUs as a Type III modification. The incremental fair value was measured as of the modification date as the excess of the fair value of the modified awards over the fair value of the original awards immediately prior to modification. The Company recognized $6.7 million of incremental compensation cost during the year ended December 31, 2025. Because the service condition had been satisfied at the modification date, the incremental compensation cost was recognized immediately. Certain awards were modified post-termination under a transition arrangement, resulting in additional stock- based compensation expense of $0.4 million during the year ended December 31, 2025. No modification charges were recorded during the year ended December 31, 2024.
Note 15 – Income Taxes The components of income (loss) before income taxes are as follows (in thousands):
Years Ended December 31, / Years Ended December 31, / Years Ended December 31,
2025 / 2024
Domestic .................................................................................................................... ... $239,568 / $(482,424)
Foreign ....................................................................................................................... ... 5,316 / 2,749
Income (loss) before income taxes ....................................................................... ... $244,884 / $(479,675)
The components of the income tax expense (benefit) are as follows (in thousands):
As of December 31, / As of December 31, / As of December 31,
2025 / 2024
Current
Federal .................................................................................................................. ... $(169) / $527
State ...................................................................................................................... ... 9,128 / 898
Foreign .................................................................................................................. ... 392 / 213
Total current tax expense ........................................................................................... ... $9,351 / $1,638
Deferred
Foreign .................................................................................................................. ... $(2,294) / $289
Total deferred tax expense (benefit) .......................................................................... ... (2,294) / 289
Total income tax expense .......................................................................................... ... $7,057 / $1,927
ASU 2023-09 Adoption The Company has early adopted the new disclosure rules found in ASU 2023-09 for the 2025 year and has elected to use the Prospective Adoption approach.
F-36
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
A reconciliation of the Company’s recorded income tax expense to the U.S. statutory rate is as follows (in thousands except percentages):
Year Ended December 31, 2025
Year Ended December 31, 2025 / Year Ended December 31, 2025 / Year Ended December 31, 2025 / Year Ended December 31, 2025
Total PTBI / $ / %
U.S. Federal Statutory Rate ........................................................... ... $244,884 / $51,426 / 21.00%
State and Local Income Taxes, Net of Federal Income Tax Effect ...................................................................................... ... 7,375 / 3.01
Foreign Tax Effects
Foreign Statutory Rate ............................................................. ... 278 / 0.11
Other nondeductible items ........................................................ ... (93) / (0.04)
Return to Provision ................................................................... ... (2,193) / (0.90)
Change in Valuation Allowance ................................................... ... 37,582 / 15.35
Nontaxable or Nondeductible Items
Forward Contract Revaluation ................................................. ... (76,300) / (31.16)
Stock-Based Compensation Expense ....................................... ... (11,960) / (4.88)
Other nondeductible items ........................................................ ... 768 / 0.31
Changes in Unrecognized Tax Benefits ........................................ ... 707 / 0.29
Other Adjustments ........................................................................ ... (532) / (0.22)
Provision for income taxes ............................................................ ... $7,057 / 2.87%
______________ (1)The jurisdiction that contributes to the majority of the tax effect in this category is Minnesota. A reconciliation of the Company’s recorded income tax expense to the U.S. statutory rate is as follows (in thousands):
Years Ended December 31,
2024
Income taxes computed at U.S. federal statutory rate ......................................................................... ... $(100,732)
State taxes ............................................................................................................................................ ... 898
Foreign rate differential ....................................................................................................................... ... 327
Forward contract revaluation ............................................................................................................... ... 84,265
Stock-based compensation ................................................................................................................... ... 5,111
Tax credits, net of FIN48 reserves ....................................................................................................... ... (3,298)
Change in valuation allowance ............................................................................................................ ... 15,712
Other .................................................................................................................................................... ... (356)
Income tax expense ......................................................................................................................... ... $1,927
Deferred income taxes arise from temporary differences between the carrying value of assets and liabilities for financial reporting purposes and income tax reporting purposes, as well as net operating losses and tax credit
F-37
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
carryforwards. Significant components of the Company’s deferred tax assets and liabilities are as follows (in thousands):
As of December 31, / As of December 31, / As of December 31,
2025 / 2024
Deferred Tax Assets:
Net operating losses .............................................................................................. ... $123,490 / $86,111
Allowances and accruals ....................................................................................... ... 29,259 / 11,107
Tax credits, net of FIN48 reserves ........................................................................ ... 30,621 / 30,876
Stock-based compensation .................................................................................... ... 10,045 / 7,438
Lease liability ........................................................................................................ ... 98,904 / 9,673
Capitalized R&D and identified intangibles ......................................................... ... 62,295 / 63,796
Other ..................................................................................................................... ... 2,482 / 439
Gross deferred tax assets ........................................................................................... ... 357,096 / 209,440
Less: Valuation Allowance ........................................................................................ ... (233,035) / (200,259)
Net deferred tax assets ............................................................................................... ... $124,061 / $9,181
Deferred Tax Liabilities:
Depreciation .......................................................................................................... ... $(23,076) / $—
Right-of-use asset ................................................................................................. ... (94,255) / (8,671)
Other ..................................................................................................................... ... (4,849) / (916)
Gross deferred tax liabilities ...................................................................................... ... (122,180) / (9,587)
Net deferred tax assets (liabilities) ............................................................................ ... $1,881 / $(406)
The realization of deferred tax assets is dependent upon the generation of sufficient taxable income of the appropriate character in future periods. The Company regularly assesses the ability to realize its deferred tax assets and establishes a valuation allowance if it is more-likely-than-not that some portion of the deferred tax assets will not be realized. The Company weighs all available positive and negative evidence, including its earnings history and results of recent operations, scheduled reversals of deferred tax liabilities, projected future taxable income, and tax planning strategies. Due to the weight of objectively verifiable negative evidence, including its history of losses in the United States, the Company believes that it is more likely than not that its U.S. federal and state deferred tax assets will not be realized. Accordingly, the Company has recorded a valuation allowance on such deferred tax assets. The valuation allowance against our various deferred tax assets increased by $32.6 million and $16.0 million during the years ended December 31, 2025, and 2024, respectively. The amount of cash paid for income taxes (net of refunds) is as follows (in thousands):
Years Ended December 31,
2025
Federal ................................................................................................................................................. ... $409
State and Local .................................................................................................................................... ... 893
Foreign - India ..................................................................................................................................... ... 397
Income taxes, net of amounts refunded .......................................................................................... ... $1,699
As of December 31, 2025, the Company had federal, state, and foreign net operating loss carryforwards in the amount of $414.8 million, $352.4 million, and $48.1 million, respectively, available to offset future taxable income. The federal net operating loss has an indefinite carryforward period but is limited to offset 80% of taxable income in
F-38
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
the year utilized. The state net operating loss carryforwards have various carryover periods and will begin to expire as early as 2036. As of December 31, 2025, the Company had federal, California, and Canadian research and development credit carryforwards of $33.7 million, $13.8 million, and $3.6 million, respectively. The federal research and development credits will begin to expire in 2038, the California research and development credits have no expiration, and the Canadian research and development credits will begin to expire in 2041. Utilization of our net operating loss and credits may be subject to annual limitations due to the ownership change limitations provided by section 382 of the Internal Revenue Code and similar state provisions. The Company’s net operating loss carryforwards and credits could expire before utilization if subject to annual limitations. The following table summarizes the activity related to the Company’s unrecognized tax benefits (in thousands):
As of December 31, / As of December 31, / As of December 31,
2025 / 2024
Gross unrecognized tax benefits, beginning of year .................................................. ... $31,545 / $25,739
Gross increases related to prior-year positions .......................................................... ... — / 34
Gross increases related to current-year positions ...................................................... ... 726 / 5,772
Gross unrecognized tax benefits, end of year ............................................................ ... $32,271 / $31,545
All of the Company’s tax years remain open for examination by U.S. federal and state tax authorities. The non- U.S. tax returns remain open for examination for the years 2021 and onwards. Due to our federal and state valuation allowance, none of the unrecognized tax benefits as of December 31, 2025, and 2024, respectively, would affect the effective tax rate if recognized. We recognize interest and penalties related to unrecognized tax benefits as income tax expense. U.S. income tax has not been recognized on the excess of the amount for financial reporting over the tax basis of investments in foreign subsidiaries that is indefinitely reinvested outside the United States. As a result of the Tax Cuts and Jobs Act (“Tax Act”), the tax impact of future distributions of foreign earnings would generally be limited to withholding tax from local jurisdictions. The amount of the deferred tax liability on the excess of the amount for financial reporting over the tax basis of investments in foreign subsidiaries is not material.
Note 16 – Leases Our lease obligations primarily consist of operating leases for our headquarters’ campus and domestic and international offices and data centers, with lease periods expiring between fiscal years 2027 and 2031. Lease costs included in measurement of lease obligations and other information related to non-cancelable operating leases were as follows (in thousands)
Years Ended December 31, / Years Ended December 31, / Years Ended December 31,
2025 / 2024
Operating lease cost ................................................................................................... ... $31,780 / $10,539
Variable lease costs ................................................................................................... ... 2,312 / 285
Short-term lease costs ............................................................................................. ... 75,333 / 8,076
Total lease costs .................................................................................................... ... $109,425 / $18,900
_______________ (1) Short-term lease costs on leases with terms of over one month and less than one year.
F-39
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
The weighted-average remaining lease terms and discount rates were as follows
As of December 31, / As of December 31, / As of December 31,
Other information ....................... 2025 / 2024
Weighted-average remaining lease term (in years) .................................................. ... 4.7 / 2.7
Weighted-average discount rate ............................................................................... ... 8.6% / 10.6%
As of December 31, 2025, future minimum lease payments of the Company’s operating lease liabilities were due as follows (in thousands):
Year ending December 31, / Operating Leases
2026 ..................................................................................................................................................... ... $66,337
2027 ..................................................................................................................................................... ... 70,073
2028 ..................................................................................................................................................... ... 59,502
2029 ..................................................................................................................................................... ... 60,244
Thereafter ............................................................................................................................................. ... 62,792
Total future lease payments ................................................................................................................. ... 318,948
Less: Imputed interest .......................................................................................................................... ... (57,126)
Present value of operating lease liabilities ........................................................................................... ... $261,822
Supplemental cash flow information related to leases was as follows (in thousands):
Years Ended December 31, / Years Ended December 31, / Years Ended December 31,
2025 / 2024
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases ............................................................ ... $23,039 / $6,442
Right-of-use assets obtained in exchange for lease obligations:
Operating leases .................................................................................................... ... $235,053 / $43,659
Leases Not Yet Commenced In late 2025, the Company executed non-cancelable lease agreements for additional data center capacity with lease commencement dates in 2026. As of December 31, 2025, the leases had not commenced and therefore are not reflected in the consolidated balance sheets. The Company will recognize operating lease right-of-use assets and corresponding lease liabilities at the commencement date based on the present value of lease payments over the respective lease terms. Aggregate undiscounted future minimum lease payments under these agreements total approximately $344.3 million over the lease term.
Note 17 – Commitments and Contingencies The Company has entered into certain contracts to receive consulting and other services that represent unconditional purchase obligations to purchase goods or services that are enforceable and legally binding. Purchase commitments exclude agreements that are cancellable without penalty and unconditional purchase commitments with a remaining term of one year or less. As of December 31, 2025, future payments related to non-cancelable commitments under these contracts are due as follows: $4.1 million (2026), and $3.0 million (2027). In the ordinary course of business, the Company may be subject from time to time to various proceedings, lawsuits, disputes, or claims. Although the Company cannot predict with assurance the outcome of any litigation, it does not believe there are currently any such actions that, if resolved unfavorably, would have a material impact on the Company’s financial condition, results of operations, or cash flows.
F-40
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Note 18 – Subsequent Events The Company has evaluated all transactions through March 31, 2026, the date these consolidated financial statements were available to be issued, and has determined that there are no other events that would require disclosure in or adjustment to these financial statements except as discussed below. Series H Redeemable Convertible Preferred Stock In January 2026, the Company entered into a Series H redeemable convertible preferred stock purchase agreement with various investors to issue up to 11,394,059 shares of the Company’s Series H redeemable convertible preferred stock. The Company raised $1.0 billion, net of issuance costs, through issuance of 11,394,059 shares of Series H redeemable convertible preferred stock at a price of $89.02 per share. The Company intends to use the proceeds for working capital and general corporate purposes. Working Capital Loan In January 2026, the Company received in cash the $1.0 billion Working Capital Loan funded by OpenAI to support the build-out of infrastructure and related capabilities required to deliver such services under the MRA. The Working Capital Loan is subject to a secured promissory note and bears interest at 6% (unless waived) with a maturity date of no later than December 31, 2032. Refer to Note 5 – Revenue for further discussion of the MRA with OpenAI. Executive Grants In February 2026, the Company’s board of directors approved equity awards to its co-founder executives, the Chief Executive Officer (“CEO”) and the Chief Technology Officer (“CTO”), consisting of RSUs and performance- based restricted stock units (“PRSUs”). The Company granted 743,902 RSUs to the CEO and 495,426 RSUs to the CTO. These RSUs vest subject to both service-based and liquidity-based vesting conditions. The service-based condition is satisfied ratably on a monthly basis beginning January 5, 2026 over periods of 48 to 60 months, subject to continued qualifying service. The liquidity-based vesting condition is expected to be satisfied upon the completion of the Company’s initial public offering, subject to continued qualifying service through such date. The Company will begin recognizing stock- based compensation expense for these awards when it is probable that the liquidity condition will be satisfied, using the accelerated attribution method over the requisite service period. The Company also granted 5,700,000 PRSUs to the CEO and 3,300,000 PRSUs to the CTO. Each PRSU represents the right to receive one share of Class B common stock upon vesting. The PRSUs vest in three equal tranches based on the achievement of market capitalization thresholds of $75 billion, $150 billion and $250 billion, respectively. Vesting may occur beginning six months following the completion of the Company’s initial public offering, subject to continued qualifying service through the applicable vesting date. Market capitalization is determined based on the 90-trading-day trailing average of the Company’s Class A common stock price multiplied by the number of outstanding shares of Class A common stock. Unvested PRSUs are forfeited upon termination of qualifying service, and any PRSUs that remain unvested as of the ninth anniversary of the completion of the Company’s initial public offering will be forfeited. In the event of a change in control, achievement of the market capitalization thresholds is determined based on the transaction price, with linear interpolation applied, as applicable. The Company is in the process of determining the grant-date fair value of these awards. The grant-date fair value of the PRSUs will reflect the effect of the market capitalization conditions. Stock-based compensation expense for the PRSUs will be recognized over the derived service period for each tranche, and only when the liquidity condition has been met.
F-41
Table o f Contents NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Leases In March 2026, the Company entered into a data center lease agreement in Canada that is expected to commence in 2026. The expected minimum lease payments are approximately $2.2 billion over a 10-year term. Concurrent with the lease, the Company entered into a stock purchase agreement with the lessor pursuant to which the lessor purchased 168,509 shares of the Company’s Class N common stock at a purchase price of $89.02 per share, for an aggregate purchase price of $15.0 million. Amazon Web Services Collaboration Agreement In March 2026, the Company entered into a term sheet with Amazon Web Services, Inc. for a multi-year strategic collaboration to deploy AI inference compute infrastructure and related services. The arrangement contemplates an initial deployment under multi-year lease arrangements, with associated recurring payments, subject to the achievement of specified technical milestones and potential expansion through additional system deployments, capacity allocations and hardware purchase options. In addition, the term sheet provides for a commitment to issue a warrant to purchase up to a maximum of 2,696,678 shares of the Company’s Class N common stock with an exercise price of $100.00 per share and a term of seven years. The warrant is expected to vest based on a combination of time- and performance-based conditions. The term sheet includes certain provisions intended to be binding, including those related to pricing, exclusivity, hardware procurement, and the warrant commitment. The completion of the contemplated transactions remains subject to the execution of definitive agreements and the satisfaction of customary conditions.
*backcover1aa.jpg*
II-1
Table of Contents
PART II INFORMATION NOT REQUIRED IN PROSPECTUS
Item 13. Other Expenses of Issuance and Distribution The following table sets forth the costs and expenses, other than underwriting discounts and commissions, payable by the registrant in connection with the sale of the Class A common stock being registered. All amounts are estimates except for the Securities and Exchange Commission (the “SEC”) registration fee, the Financial Industry Regulatory Authority (“FINRA”) filing fee, and the Nasdaq Stock Market LLC listing fee.
Amount to Be Paid
SEC registration fee .............................................................................................................................. ... $13,810
FINRA filing fee ................................................................................................................................... ... 15,000
Nasdaq Stock Market LLC listing fee .................................................................................................. ... 25,000
Transfer agent’s fees and expenses ....................................................................................................... ... *
Printing and engraving expenses .......................................................................................................... ... *
Legal fees and expenses ........................................................................................................................ ... *
Accounting fees and expenses .............................................................................................................. ... *
Blue Sky fees and expenses .................................................................................................................. ... *
Miscellaneous expenses ........................................................................................................................ ... *
Total ................................................................................................................................................. ... $ *
_______________ *To be completed by amendment.
Item 14. Indemnification of Directors and Officers Section 145 of the Delaware General Corporation Law provides that a corporation may indemnify directors and officers as well as other employees and individuals against expenses (including attorneys’ fees), judgments, fines, and amounts paid in settlement actually and reasonably incurred by such person in connection with any threatened, pending, or completed actions, suits, or proceedings in which such person is made a party by reason of such person being or having been a director, officer, employee, or agent to the registrant. The Delaware General Corporation Law provides that Section 145 is not exclusive of other rights to which those seeking indemnification may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors, or otherwise. Article 9 of the registrant’s amended and restated certificate of incorporation, to be in effect immediately prior to the completion of this offering, provides for indemnification by the registrant of its directors, officers, and employees to the fullest extent permitted by the Delaware General Corporation Law. The registrant has entered or will enter into indemnification agreements with each of its current directors, executive officers, and certain other officers to provide these directors and officers additional contractual assurances regarding the scope of the indemnification set forth in the registrant’s amended and restated certificate of incorporation and amended and restated bylaws, each to be in effect immediately prior to the completion of this offering, and to provide additional procedural protections. There is no pending litigation or proceeding involving a director or executive officer of the registrant for which indemnification is sought. Section 102(b)(7) of the Delaware General Corporation Law permits a corporation to provide in its certificate of incorporation that a director or officer of the corporation shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director or officer, except for liability (i) for any breach of the director’s or officer’s duty of loyalty to the corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) in the case of directors, for unlawful payments of dividends or unlawful stock repurchases, redemptions, or other distributions, or (iv) for any transaction from which the director or officer derived an improper personal benefit, provided that
II-2
Table of Contents
officers may not be indemnified for actions by or in the right of the corporation. The registrant’s amended and restated certificate of incorporation, to be in effect immediately prior to the completion of this offering, provides for such limitation of liability. The registrant maintains standard policies of insurance under which coverage is provided (a) to its directors and officers against loss rising from claims made by reason of breach of duty or other wrongful act and (b) to the registrant with respect to payments that may be made by the registrant to such officers and directors pursuant to the above indemnification provision or otherwise as a matter of law. The proposed form of underwriting agreement to be filed as Exhibit 1.1 to this registration statement provides for indemnification of directors and officers of the registrant by the underwriters against certain liabilities.
Item 15. Recent Sales of Unregistered Securities Since January 1, 2023, the registrant made sales of the following unregistered securities: Option, Warrant, and Common Stock Issuances From January 1, 2023 to December 31, 2024, the registrant granted to its employees, consultants, and other service providers options to purchase an aggregate of 72,792,724 shares of its Class B common stock under its 2016 Equity Incentive Plan (as amended, the “2016 Plan”), at exercise prices ranging from $0.09 to $13.01 per share. From January 1, 2023 to December 31, 2024, the registrant issued and sold to its employees, consultants, and other service providers an aggregate of 30,176,004 shares of its Class B common stock upon the exercise of stock options under its 2016 Plan, at exercise prices ranging from $0.09 to $13.01 per share, for a weighted-average exercise price of $2.28. Since January 1, 2025, the registrant issued and sold to its employees, consultants, and other service providers an aggregate of shares of its Class B common stock upon the exercise of stock options under its 2016 Plan, at exercise prices ranging from $ to $ per share, for a weighted-average exercise price of $ . From January 1, 2023 to December 31, 2024, the registrant granted to its employees, consultants, and other service providers restricted stock units covering an aggregate of 2,111,636 shares of its Class B common stock under its 2016 Plan. Since January 1, 2025, the registrant granted to its employees, consultants, and other service providers restricted stock units covering an aggregate of shares of its Class B common stock under its 2016 Plan. In August 2022, the registrant sold an aggregate of 599,880 shares of its Class B common stock to an accredited investor at a purchase price of $16.7525 per share, for an aggregate purchase price of $10.0 million. In December 2025, the registrant issued a warrant to purchase up to 1,857,516 shares of its Class N common stock at an exercise price of $0.01 per share. In December 2025, the registrant issued a warrant to purchase up to 33,445,026 shares of its Class N common stock at an exercise price of $0.00001 per share. In January 2026, the registrant sold an aggregate of 1,857,516 shares of its Class N common stock to an accredited investor at a purchase price of $0.01 per share, for an aggregate purchase price of $18.6 thousand. In January 2026, the registrant sold an aggregate of 168,509 shares of its Class N common stock to an accredited investor at a purchase price of $89.0156 per share, for an aggregate purchase price of $15.0 million.
II-3
Table of Contents
In April 2026, the registrant issued a warrant to purchase up to 1,655,975 shares of its Class N common stock at an exercise price of $0.01 per share. In April 2026, the registrant sold an aggregate of 1,655,975 shares of its Class N common stock to an accredited investor at a purchase price of $0.01 per share, for an aggregate purchase price of $16.6 thousand. Redeemable Convertible Preferred Stock Issuances In July and August 2024, the registrant sold an aggregate of 2,728,512 shares of its Series F-1 redeemable convertible preferred stock to five accredited investors at a purchase price of $14.66 per share, for an aggregate purchase price of $40.0 million. In September 2024, the registrant issued and sold 3,069,577 shares of its Series F-1 redeemable convertible preferred stock to an accredited investor at a purchase price of $14.66 per share, for a purchase price of $45.0 million. In August 2024, the registrant issued 68,213 shares of its Series E redeemable convertible preferred stock to an accredited investor pursuant to a warrant with an exercise price of $0.00001 per share. In September and October 2025, the registrant sold an aggregate of 30,359,557 shares of its Series G redeemable convertible preferred stock to five accredited investors at a purchase price of $36.2324 per share, for an aggregate purchase price of $1.1 billion. In January and February 2026, the registrant sold an aggregate of 11,394,059 shares of its Series H redeemable convertible preferred stock to accredited investors at a purchase price of $89.0156 per share, for an aggregate purchase price of $1.0 billion. The registrant believes these offers, sales, and issuances were exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), in reliance upon Section 4(a)(2) of the Securities Act or Regulation D promulgated thereunder, or Rule 701 promulgated under the Securities Act as transactions by an issuer not involving a public offering or pursuant to benefit plans and contracts relating to compensation as provided under Rule 701. The recipients of the securities in each of these transactions represented their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends were placed upon the stock certificates issued in these transactions. All recipients had adequate access, through their relationships with the registrant, to information about the registrant.
Item 16. Exhibits and Financial Statement Schedules See the Exhibit Index attached to this registration statement, which Exhibit Index is incorporated herein by reference. Schedules not listed above have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements or notes thereto.
Item 17. Undertakings (a)Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer, or controlling person of the registrant in the successful defense of any action, suit, or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered hereunder, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question of whether
II-4
Table of Contents
such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. (b)The undersigned registrant hereby undertakes that: (1)For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective. (2)For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
II-5
Table of Contents
EXHIBIT INDEX
Exhibit Number / Exhibit Description
1.1* .................................... Form of Underwriting Agreement
3.1 ..................................... Amended and Restated Certificate of Incorporation, as amended, as currently in effect
3.2 ..................................... Form of Amended and Restated Certificate of Incorporation, to be in effect immediately prior to the completion of this offering
3.3 ..................................... Bylaws, as currently in effect
3.4 ..................................... Form of Amended and Restated Bylaws, to be in effect immediately prior to the completion of this offering
4.1 ..................................... Reference is made to Exhibits 3.1 through 3.4
4.2 ..................................... Form of Class A Common Stock Certificate
4.3 ..................................... Amended and Restated Investors’ Rights Agreement, dated as of January 28, 2026, by and among the Registrant and the investors listed therein
5.1* .................................... Opinion of Latham & Watkins LLP
10.1(a) ................................. Standard Industrial/Commercial Single-Tenant Lease, dated as of January 27, 2022, by and between the Registrant and Xinbei Tech, Inc.
10.1(b) ................................. First Amendment to Standard Industrial/Commercial Single-Tenant Lease, dated as of June 2, 2023, by and between the Registrant and Xinbei Tech, Inc.
10.1(c) ................................. Second Amendment to Standard Industrial/Commercial Single-Tenant Lease, dated as of June 4, 2024, by and between the Registrant and Xinbei Tech, Inc.
10.2(a)# ................................ 2016 Equity Incentive Plan, as amended
10.2(b)# ................................ Form of Notice of Stock Option Grant and Stock Option Agreement under the 2016 Equity Incentive Plan
10.2(c)# ................................ Form of Notice of Restricted Stock Unit Award Grant and Restricted Stock Unit Agreement under the 2016 Equity Incentive Plan
10.3(a)# ................................ 2026 Incentive Award Plan
10.3(b)# ................................ Form of Stock Option Grant Notice and Stock Option Agreement under the 2026 Incentive Award Plan
10.3(c)# ................................ Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2026 Incentive Award Plan
10.4# ................................... 2026 Employee Stock Purchase Plan
10.5# ................................... Non-Employee Director Compensation Program
10.6# ................................... Form of Indemnification and Advancement Agreement between the Registrant and each of its Directors and Executive Officers
10.7# ................................... Executive Change in Control and Severance Plan
10.8# ................................... Continued Employment Offer Letter, dated as of March 22, 2026, by and between the Registrant and Andrew D. Feldman
10.9# ................................... Continued Employment Offer Letter, dated as of March 22, 2026, by and between the Registrant and Sean Lie
10.10# .................................. Amended and Restated Employment Offer Letter, dated as of March 25, 2026, by and between the Registrant and Dhiraj Mallick
10.11†+ ................................. Master Relationship Agreement, dated as of December 24, 2025, by and between the Registrant and OpenAI OpCo, LLC
10.12† .................................. Secured Promissory Note, dated as of January 5, 2026, by and between the Registrant and OpenAI OpCo, LLC
10.13† .................................. Warrant to Purchase Class N Common Stock, dated as of December 24, 2025, by and between the Registrant and OpenAI OpCo, LLC
10.14 ................................... Registration Rights Agreement, dated as of December 24, 2025, by and between the Registrant and OpenAI OpCo, LLC
10.15†+ ................................. Framework Agreement for the Supply of Goods, dated as of September 13, 2023, by and between the Registrant and G42 Holding US LLC
II-6
Table of Contents
Exhibit Number / Exhibit Description
10.16†+ ................................. Purchase Order, dated as of November 5, 2025, by and between the Registrant and Mohamed bin Zayed University of Artificial Intelligence
10.17†+ ................................. Purchase Order, dated as of December 30, 2025, by and between the Registrant and Mohamed bin Zayed University of Artificial Intelligence
10.18+ .................................. Revolving Credit and Guaranty Agreement, dated as of April 14, 2026, by and among the Registrant, the obligors, lenders, and issuing banks party thereto, and Morgan Stanley Senior Funding, Inc., as administrative agent and collateral agent.
16.1 .................................... Letter Regarding Change in Certifying Accountant
21.1 .................................... List of Subsidiaries of the Registrant
23.1 .................................... Consent of BDO USA, P.C., independent registered public accounting firm
23.2 .................................... Consent of KPMG LLP, independent registered public accounting firm
23.3* ................................... Consent of Latham & Watkins LLP (included in Exhibit 5.1)
24.1 .................................... Power of Attorney (reference is made to the signature page to the Registration Statement)
107.1 ................................... Filing Fee Table
_______________ *To be filed by amendment.
†Portions of this exhibit (indicated by asterisks) have been omitted in accordance with Item 601(b)(10)(iv) of Regulation S-K because they are both not material and are the type that the Registrant treats as private or confidential. +Portions of this exhibit have been omitted in accordance with Item 601(a)(5) of Regulation S-K. The Registrant undertakes to furnish a copy of all omitted schedules and exhibits to the SEC upon its request.
II-7
Table of Contents
SIGNATURES Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Sunnyvale, State of California, on the 17th day of April, 2026.
| CEREBRAS SYSTEMS INC. | CEREBRAS SYSTEMS INC. |
|---|---|
| By: | /s/ Andrew D. Feldman |
| Name: | Andrew D. Feldman |
| Title: | Chief Executive Officer |
POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Andrew D. Feldman, Robert Komin, and Shirley X. Li, and each of them, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place, and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement and any and all additional registration statements pursuant to Rule 462(b) of the Securities Act of 1933, as amended, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto each said attorney-in-fact and agents full power and authority to do and perform each and every act in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or either of them or their or his or her substitute or substitutes may lawfully do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
Signature / Title / Date
/s/ Andrew D. Feldman ................... Chief Executive Officer, President, and Director (Principal Executive Officer) / April 17, 2026
Andrew D. Feldman ....................... Chief Executive Officer, President, and Director (Principal Executive Officer) / April 17, 2026
/s/ Robert Komin ........................ Chief Financial Officer (Principal Financial Officer) / April 17, 2026
Robert Komin ............................ Chief Financial Officer (Principal Financial Officer) / April 17, 2026
/s/ Yagnesh Patel ....................... Chief Accounting Officer (Principal Accounting Officer) / April 17, 2026
Yagnesh Patel ........................... Chief Accounting Officer (Principal Accounting Officer) / April 17, 2026
/s/ Paul Auvil .......................... Director / April 17, 2026
Paul Auvil .............................. Director / April 17, 2026
/s/ Elena Donio ......................... Director / April 17, 2026
Elena Donio ............................. Director / April 17, 2026
/s/ Lior Susan .......................... Director / April 17, 2026
Lior Susan .............................. Director / April 17, 2026
/s/ Steve Vassallo ...................... Director / April 17, 2026
Steve Vassallo .......................... Director / April 17, 2026
/s/ Eric Vishria ........................ Director / April 17, 2026
Eric Vishria ............................ Director / April 17, 2026
